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Lu Li, Ph.D. 
University of Connecticut, 2018 
 
In this study, we report two previously unidentified mechanisms that governs β-lactam 
and antimicrobial peptide resistance.  
In Gram-negative bacteria, production of β-lactamases is often induced in response to 
the antibiotic- associated damage to the cell wall. Here, we have identified a previously 
unidentified mechanism that governs β-lactamase production. In the Gram-negative 
enteric pathogen Vibrio parahaemolyticus, we found a histidine kinase/response 
regulator pair (VbrK/VbrR) that controls expression of a β-lactamase. Mutants lacking 
either VbrK or VbrR do not produce the β-lactamase and are no longer resistant to β-
lactam antibiotics. Notably, VbrK autophosphorylation is activated by β-lactam 
antibiotics, but not by other lactams. However, single amino acid substitutions in the 
putative periplasmic binding pocket of VbrK leads its phosphorylation in response to 
both β-lactam and other lactams, suggesting that this kinase is a β-lactam receptor that 
can directly detect β-lactam antibiotics instead of detecting the damage to cell wall 
resulting from β-lactams. In strong support of this idea, we found that purified 
periplasmic sensor domain of VbrK binds penicillin, and that such binding is critical for 
VbrK autophosphorylation and β lactamase production. Direct recognition of β-lactam 
antibiotics by a histidine kinase receptor may represent an evolutionarily favorable 
mechanism to defend against β-lactam antibiotics. 
 
Lu Li, University of Connecticut, 2018 
 
Antimicrobial peptide is amphipathic peptide that inserts into phospholipid bilayer and 
disrupt the integrity of bacterial cell membrane. Many bacteria employ the strategy of 
LPS modification to resist attack from AMPs. Here, we have identified a mechanism that 
governs LPS modification that has never been reported in Vibrio parahaemolyticus 
before. We identified a histidine kinase/response regulator pair (PvrK/PvrR) that 
controls expression a lipid A ethanolamine phosphotransferase (PEA transferase), an 
enzyme adds positively charged phosphoethanolamine (PEA) to the core of lipid A. 
Resistance to AMPs or the expression of PEA transferase drastically decrease in 
mutants lacking either PvrK or PvrR. The autophosphorylation of PvrK can be 
stimulated through either low Mg2+ concentration or the presence of AMPs, which 
resembles the host environment when Vibrio parahaemolyticus invades the host.    
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Chapter 1. Literature Review and General Introduction 
1.1 Antibiotic resistant Vibrio parahaemolyticus 
1.1.1 Vibrio parahaemolyticus as pathogenic bacteria 
The discovery of antibiotics is a remarkable step forward in the history of human 
medicine. As many antibiotics are derivatives of bacterial or fungus secretion, and also 
because of widespread use of antibiotics in morden medicine, antibiotic resistance 
among bacteria is becoming more and more prevalent. Understanding the differential 
mechanisms by which bacteria become resistant as well as the systems bacteria apply 
to regulate their antibiotic resistance has been the focus of study for many scientists.  
 
Vibrio parahaemolyticus is gram negative bacterium that can be generally found in 
blackish saltwater. When ingested, it can cause gastrointestinal illness in humans. In 
most of the cases, ingestions of undercooked shellfish particularly oysters is considered 
the route of transmission. However, in some cases, cooked seafood is responsible for 
most of the outbreaks.  It is believed that errors in refrigeration, cooking or food-
handling hygiene contributed to the incidents (1). The symptoms include watery 
diarrhea, abdominal cramping, nausea, vomiting, fever and chills. If individuals get 
infected with V. parahaemolyticus. Through wounded skin, abscesses with localized 
cellulites may develop (2). The illnesses caused by V. parahaemolyticus in most cases 
are self-limited. Complications may arise if the affected individual has a compromised 
immune system or preexisting medical conditions such as liver diseases or diabetes (3). 
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5% of the infections advanced to septicemia and nearly half of the cases become fatal 
(4).  
Strains of V. parahaemolyticus are typically serotyped based on somatic(O) antigens 
and capsular (K) antigens. So far, 12 O groups and 71 K groups have been reported 
(5). In 1996, a unique serotype O3:K6 emerged and quickly spread from India to 
worldwide(6). In 1998, two V. parahaemolyticus outbreaks in New York state were 
associated with O3:K6 strains (7), it then spread further to Chile and Europe, caused 
thousands of infections and illnesses and resulted in several V. parahaemolyticus 
pandemics (8, 9) .   
The whole genome sequencing of clinical strain RIMD2210633 found confirmed that V. 
parahaemolyticus contained two circular chromosomes of 3,288,558 bp and 1,877,212 
bp and 4832 genes (10). Most of the genes required for growth and viability are on 
chromosome 1, while more genes on chromosome 2 are related to transcriptional 
regulation and virulence factors, including pathogenicity island (PAI), the thermostable 
direct haemolysin gene(tdh), tdh-related haemolysin gene (trh) and type III secretion 
systems (10).  
TDH was considered one of the primary virulence factors of V. parahaemolyticus. It 
forms a ~2nm pores on erythrocytes (11) and alters cl- and ca2+secretion of human 
colonic epithelial cells that is responsible for the development of diarrhea (12, 13). TRH 
is a heat labile protein and immunologically similar to TDH (14), it also activate cl- 
channels and alters ion flux in small intestine (13). Although most of the clinical strains 
contain either TDH or TRH, identification of clinical strains that contain neither toxins 
indicate the existence of other important virulence factors that contribute to the 
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pathogenicity of V. parahaemolyticus (15, 16) . This corresponds to one of the findings 
where both TDH positive and negative strains of V. parahaemolyticus can disrupt 
epithelial cell tight junctions (17). In another study, deletion of tdh genes completely 
abolished the hemolytic activity but did not affect the cytotoxicity to HeLa cells. It was 
also showed that tdh mutant can still cause fluid accumulation in the rabbit ileal loop 
(18). All these results indicate that TDH and TRH alone are not fully responsible for the 
cytotoxicity and enterotoxicity of pathogenic V. parahaemolyticus.  
Type III of secretion system (T3SS) is another important virulence factor of V. 
parahaemolyticus. It is a protein appendage found in many gram negative, pathogenic 
bacteria. It is a needle like structure the composed of various structural proteins and 
functional proteins. It functions as a sensory probe to detect the presence of its target 
eukaryotic cells and is able to inject corresponding toxins into host cells. The strain 
RIMD2210633 composes two type III of secretion systems: T3SS1 and T3SS2. T3SS1 
is present in both pathogenic and non-pathogenic strains of V. parahaemolyticus, and is 
responsible for cytotoxic activity(19), cell death and autophagy (20), and lethality in mice 
(21); on the other hand, T3SS2 is only present in pathogenic strains (22) and is 
associated with enterotoxicity (19, 21) and probably adaption of the bacteria to 
environmental fitness (23). It is found that, several bile salts can activate transcriptional 
factors vtrA and vtrB encoded in the PAI region of the bacteria, and further activate the 
expression of T3SS2 components (24, 25). Important effector proteins of T3SS2 include 
VopC, which mediates cdc42-dependent invasion of intestinal epithelial cells (26), VopL, 
which promotes the assembly of actin filaments, VopV, which induces rearrangement of 
the apical epithelial membrane through its interaction with actin or with actin cross-
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linking protein filaments (27) and VopZ, which inactivate both MAPK signaling pathway 
by preventing the activation of TAK1 (28). All these effectors collectively are essential 
for intestinal colonization, induction of diarrhea and general intestinal pathology.  
  
1.1.2 Resistance of V. parahaemolyticus to antibiotics 
1.1.2.1 General situation of antibiotic resistance worldwide 
Dates back to 1928, the prototype of the first antibiotic penicillin: the “mold juice”, was 
discovered by Alexander Fleming. In 1940’s, antibiotic application was introduced to the 
public thanks to the World War II. Since then, more and more different antibiotics were 
discovered modified, produced, and widely used through the world.  
In the United States, it is reported that over 250 million antibiotic prescriptions are made 
every year (29). In agriculture, antibiotics are used as veterinary medicine and feed 
additives for livestock and poultry (30, 31).  Antibiotics enter environment through 
animal manure and human waste, and can persist in the environment for years (32, 33). 
This has resulted in an unprecedented global increase in the incidences of bacteria 
strains that are of multiple resistance to different antibiotics. Antibiotic resistance now is 
becoming a more and more severe problem and has become a health crisis worldwide. 
Each year in the United States, at least 2 million people become infected with bacteria 
that are resistant to antibiotics and at least 23,000 people die each year as a direct 
result of these infections (34). It is essential to understand where resistant pathogens 
emerge, how drug resistance is conferred and transmitted among pathogens, and how 
pathogens regulate those resistance genes.  
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 1.1.2.2 Mechanisms of antibiotic resistance 
Development of antibiotic resistance in bacteria is inevitable and is natural result of 
evolution. Since most of the antibiotics are derived secretions of fungus or bacteria 
itself, antibiotic resistance was recorded even before the first clinical use of penicillin in 
1940’s (35). There are five major antibiotic targets: bacterial cell wall, DNA synthesis, 
RNA synthesis, protein synthesis and folic acid metabolism. Resistance to antibiotics 
occurs through four basic mechanism: enzyme destruction, target modification, efflux 
systems, and immunity and bypass. For enzyme destruction, many species of bacteria 
have developed or acquired the ability to produce enzymes to digest various antibiotics. 
The most classical example is b-lactamase, an enzyme that can directly break the four-
atom ring of b-lactam antibiotics family, including penicillin, carbenicillin and 
cephalosporins. For target modification, the bacteria modify the structure or composition 
so that the antibiotics can longer bind to its original target. For example, methicillin-
resistant Staphylococcus aureus (MRSA) achieves high-level resistance to methicillin 
and other b-lactam antibiotics through acquisition and expression of the mecA gene (36, 
37). As the family of b-lactam antibiotics destruct bacteria cell wall by binding to 
penicillin-binding protein (PBP), an enzyme that functions in cell wall peptidoglycan 
synthesis, the mecA gene encodes an alternative penicillin-binding protein 2a (PBP2a) 
that has a low affinity for beta-lactam antibiotics, hence prevents the cell wall synthesis 
being inhibited by the antibiotics. The efflux system is one of the major causes of 
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multidrug-resistance in bacteria. They can confer resistance not only to antibiotics but 
also other substances produced by the host, such as bile, hormones and other host-
defense molecules. There are five major families of the efflux-pump proteins, including 
ATP-binding cassette (ABC) superfamily, the major facilitator superfamily (MFS), the 
multidrug and toxic-compound extrusion (MATE) family, the small multidrug resistance 
(SMR) family and the resistance nodulation division (RND) family (38). One of the 
model systems is AcrAB- TolC multidrug efflux pump in E.coli. It is composed a 
transporter protein AcrB which is located in the inner membrane; a membrane-fusion 
protein AcrA, which is located in the periplasmic space; and a channel protein TolC, 
which is located in the outer membrane. The AcrB captures substrate (antibiotics) from 
the cytoplasm or inner membrane and transport them through TolC to the extracellular 
space. The cooperation between AcrB and TolC is through AcrA, whose dynamics is 
drived by the proton motive force (39, 40). The best example of bacterial immunity to 
antibiotics (and various other environmental stresses) is bacterial biofilm. The biofilm is 
an organic matrix usually attached to a surface. It is a polymer of various different 
components secreted by the bacteria population including polysaccharides, proteins, 
and nucleic acid. The bacterial population is embedded within this matrix where they 
develop into physiological status that is different to the planktonic form (41), thus endow 
the population distinctive immunity to numerous environmental stresses, including its 
inherent resistance to antimicrobial agents. One hypothesis says that the complex 
matrix itself is a formidable penetration barrier to many antimicrobial agents, and this 
theory has been proved by several experiments and mathematical models (42, 43). A 
second theory is that some of the cells in the biofilm experience nutrition limitation and 
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undergo into a starvation or dormant status, and starved cells in many cases are not 
sensitive to many different antibiotics (44, 45).  
 
 
 
1.1.2.3 Resistance of V. parahaemolyticus to b-lactam antibiotics 
The b-lactams are the most widely used and among the most valuable classes of 
antibiotics (46). These agents contain a β-lactam ring in their structures and inhibit the 
activity of transpeptidases or penicillin binding proteins (PBPs), the essential enzymes 
for the biosynthesis of peptidoglycan (PG) (47, 48), thereby damaging the integrity of 
bacterial cell wall.  
 
Although antibiotic resistance of V. parahaemolyticus is not the focus of research as 
other enteric pathogens such as Vibrio cholera or Salmonella spp., all available studies 
and surveys so far have reached to a consensus that β-lactam resistance in V. 
parahaemolyticus is most prevalent and nonnegligible. A very high ampicillin resistance 
rate was observed in pathogenic V. parahaemolyticus strains in the United States as 
early as 1978, in an endemic of V. parahaemolyticus infection (49). In more recent 
surveys carried out still in the US, of 168 V. parahaemolyticus isolates, more than 80% 
were found resistant to ampicillin(MIC=32ug/ml) (50, 51). In one study carried out in 
Europe, 107 V. parahaemolyticus strains were analyzed for antimicrobial susceptibility, 
62% of all strains were resistant to four different classes of antibiotics and all isolates 
 8 
(100%) were resistant to ampicillin and amoxicillin. Of all the strains analyzed, 20 
strains were clinical isolates (52). In a study carried out in Brazil, 90% of the V. 
parahaemolyticus isolates derived from either fresh or frozen seafood were confirmed 
resistant to ampicillin (53). Studies from Asia or other regions of the world also reported 
similar results that resistance to β-lactam in V. parahaemolyticus is dominant. However, 
the mechanism and regulatory of β-lactam resistance in V. parahaemolyticus remains 
unclear.  
 
In general, there are three primary mechanisms by which bacteria develop against 
resistance toward β-lactam antibiotics. One of the principal mechanisms by which 
bacteria develop resistance to β-lactam antibiotics is the production of intrinsic or 
horizontally acquired β-lactamases that can degrade and inactivate β-lactams (54). In 
many bacterial species, β-lactamase expression is inducible in response to β-lactam 
antibiotic treatment. For example, in Gram positive bacteria, β-lactamase can be 
induced directly by β-lactam antibiotics or indirectly by muropeptides that are released 
from PG after β-lactam treatment (55). In Gram-negative bacteria (e.g., 
Enterobacteriaceae), muropeptide produced after β-lactam treatment can also induce 
the expression β-lactamase (56, 57). In addition to β-lactam treatment, β-lactamase 
expression in Gram-negative bacteria can also be induced by the changes of growth 
rate (58, 59) The direct role of β-lactam in inducing the expression of β-lactamase in 
Gram-negative bacteria has not been reported. Except for β-lactamase, another 
mechanism of β-lactam resistance is, as mentioned above, through the alteration of the 
antibiotic target site, which is a major cause of the resistance in gram positive 
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pathogens including Staphylococcal and Streptococcal species. The final mechanism is 
prevention of access of the antibiotic to the target by way of altered permeability or 
forced efflux. For example, this can be performed by the MexA,B–OprM antibiotic efflux 
pump, which is a major cause of resistance in Pseudomonas and in other pathogenic 
Gram-negative species (60).  
 
1.1.2.4 Resistance of V. parahaemolyticus to antimicrobial peptide  
Antimicrobial peptides (AMPs) is part of the host innate immune response, study 
showed that knockout mice with deficiencies in AMP production exhibited great 
susceptibility to bacterial infection of skin and mucosal surfaces (61). Some 
antimicrobial peptides have already been applied for clinical use, such as polymyxin B, 
ambicin (nisin) and polymyxin E. Although there has been continuous debate over the 
mechanism of action, all the theories are based on the cationic and sometimes 
amphipathic nature of the substance. In either theory, the initial interaction between the 
AMPs and target cell membrane is electrostatic, since the surface of cell envelop is 
always anionic. When the concentration of peptides lying on the cell membrane reaches 
to a threshold, the peptides insert themselves into the membrane and changes the 
thickness or integrity of the membrane. Different insertion theories include peptide-lined 
pores in the barrel-stave model, solubilize the membrane into micellar structure in the 
carpet model, or form peptide-and-lipid-lined pores in the toroidal pore model (62). The 
cell envelop can be totally destructed by the AMP, which directly leads to the lysis of the 
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cell. Alternatively, the AMPs can get into cell and further affect other functions of the 
cell, such as protein synthesis or proper functioning of the RNA polymerase.  
As the microbes always find way to co-evolve with host’s immune system, the 
pathogens employ several strategies to fight against AMPs. The most employed 
strategy is through cell surface modification. In Gram negative bacteria, the outer leaflet 
of the outer membrane is mainly composed of lipopolysaccharide (LPS), which include 
three components: lipid A, core polysaccharide, and an O antigen. The lipid A is 
essentially an anionic dimer of glucosamine linked to fatty acid chains and flanked by 
polar phosphate groups. To prevent anionic phosphate groups repelling each other and 
disturbing the stability of the outer membrane, divalent cationic ions such as Mg2+ or 
Ca2+ are attracted to LPS. Displacement of the cations by AMPs makes bacteria 
vulnerable to its attacks. Pathogens make various modifications to lipid A component to 
make it more neutral electronically. For example, Salmonella enterica and 
Pseudomonas aeruginosa developed AMP resistance by adding 4-aminoarabinose 
(Ara4N) to the phosphate group of the lipid A backbone (63, 64). In another example for 
S. enterica, the product of pagP increased acylation level of lipid A (65). The net effect 
of all these substitutions is to render a more neutral LPS and repel positively-charged 
AMPs before they can reach the cytoplasmic membrane. The second way of adaption 
the allows certain bacteria to avoid being killed by AMP is to directly bind or neutralize 
AMP. A secreted protein of Staphylococcus aureus known as staphylokinase can 
directly bind alpha-defensins produced by neutrophils (66). Other resistance 
mechanisms include efflux and proteolytic degradation of AMPs (67).  
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So far, no documentation or study has reported on the susceptibility of V. 
parahaemolyticus to AMPs. As antibiotics belonging to AMP family are considered the 
last resort of antibiotic treatment, it is important to find out whether the bacteria employ 
any strategy to make itself more resistant, and if any, how does the bacteria regulate 
expression of resistance genes.  
 
1.2 Two component regulatory system 
Like all other life forms on the earth, microorganisms are facing environmental 
fluctuations all the time. No matter whether the bacteria is in a planktonic form or is 
infecting a host, availability of nutrients like carbons, oxygen, nitrogen, or environmental 
conditions such as temperature, acidity, osmotic pressure and toxic substances etc. can 
change quickly and drastically. The organisms have to constantly adjust to the dynamic 
surroundings in order to survive, and such an adaption always rely on changing in 
expression of a specific set of genes. One of such implements is known as two 
component regulatory systems (TCSs) 
 
A simplified model of TCS consist of a histidine kinase (HK) and a response regulator 
(RR). In gram negative bacteria, HKs are inner membrane proteins which contains a N- 
terminal sensor domain in periplasmic region that monitor environmental stimuli, a 
transmembrane domain that anchors the protein, and a C- terminal cytoplasmic domain 
that binds to ATP and transfers signals. Upon detection of a specific signal, the sensor 
domain changes its confirmation and results in autophosphorylation of conserved 
histidine residue (His) in the cytoplasmic domain. The phosphoryl groups in most cases 
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are from the gamma-phosphoryl group in ATP. The cognate RR further catalyzes the 
transfer of phosphoryl group from activated HK to RR’s conserved aspartate (Asp). 
Typically, upon phosphorylation, RR undergoes conformational change, and RR’s 
output domain which is most frequently a helix-turn-helix DNA-binding domain, changes 
its affinity to specific DNA elements so as to modify DNA transcription. (68, 69). Other 
types of RR output domain include those with enzymatic functions, for example, 
GGDEF diguanylate cyclases, EAL c-di-GMP phosphodiesterases, and CheB-like 
methylesterases (70). Except for being a kinase, some HKs also function as 
phosphatase that it can catalyze dephosphorylation of RR, where phosphoryl group is 
transferred to water, and the whole system returns to pre-activation state.  In a more 
complex scheme, an HK may contain multiple signal transducing domains, including 
one or more Asp-containing receiver domains at the C- terminus. This kind of HK is 
usually known as a “hybrid” protein.  In other cases, more proteins are involved in the 
multiple phosphotransfer processes which is called a phosphorelay.  
 
TCSs can be found in all domains of organism, and it is one of the most prevalent 
systems in prokaryotes. The number of TCSs vary greatly in different microbes, ranging 
from 0 in 
Mycoplasma genitalium to 80 in Synechocystis spp (71, 72). In the V. parahaemolyticus, 
it is predicted through genome sequencing alignment that it contains more than 50 pairs 
of HKs and RRs. Genes of functionally coupled HKs and RRs are often encoded 
adjacent to one another, forming an operon. And this arrangement is always an 
indicative of a cognate TCS (70). Interestingly, cross-talks between two or more TCSs 
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do have been observed in many studies. In a study that covered transcriptome analysis 
of all the TCSs in E.coli, it was found that the overall TCSs form a network of functional 
interactions. For example, cellular functions such as flagellar synthesis and expression 
of the RpoS regulon were affected by multiple two-component systems (73); on the 
contrary, one TCS always simultaneously monitor multiple environmental signals and 
affect transcriptional level of many different genes. In some cases, a HK can 
phosphorylate a non-cognate RR when the cognate RR is mutated and non-functional 
(74).  
 
Many virulence and antibiotic resistance gene are regulated by TCSs in pathogens. For 
example, in Salmonella typhimurium, strains with phoP(HK) or phoQ (RR) mutations 
have decreased survival in cultured mouse macrophages (75). PhoP-PhoQ TCS is also 
involved in resistance of antimicrobial peptides by monitoring periplasmic 
concentrations of Mg2+ and the sub-lethal concentrations of antimicrobial peptides itself 
(76, 77). In enterohemorrhagic Escherichia coli (EHEC) O157:H7, the expression of a 
conserved pathogenicity island known as locus of enterocyte effacement (LEE) is under 
control of quorum sensing. The autoinducer 3 (AI-3) directly activate the TCS of QseC-
QseB and controls LEE1 gene expression. The QseC-QseB also controls expression of 
other virulence genes such as flagella and motility genes (78, 79).  In gram positive 
bacteria, VanS (HK) directly binds to vancomycin, leading to the expression of genes 
that are required for the synthesis of alternate peptidoglycan precursors that have low 
affinity for vancomycin (80-82). Despite the evidence that TCS plays an important role in 
the induction of virulence and antibiotic resistance of pathogen, it remains unclear to 
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many TCSs what environmental stimuli activate the system in the first place. So far, 
very few research investigated the TCSs in Vibrio spp., and no research has 
investigated the role TCSs play in the virulence and antibiotic resistance of V. 
parahaemolyticus. 
 
 
 
 
 
 
Chapter 2. Sensor histidine kinase is a β-lactam receptor and 
induces resistance to β-lactam antibiotics 
 
2.1 Introduction 
The β-lactams are the most widely used and among the most valuable classes of 
antibiotics (83). These agents contain a β-lactam ring in their structures and inhibit the 
activity of transpeptidases or penicillin binding proteins (PBPs), the essential enzymes 
for the biosynthesis of peptidoglycan (PG) (47, 48), thereby damaging the integrity of 
bacterial cell wall. One of the principal mechanisms by which bacteria develop 
resistance to β-lactam antibiotics is the production of intrinsic or horizontally acquired β-
lactamases that can degrade and inactivate β-lactams (54).  
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In many bacterial species, β-lactamase expression is inducible in response to β-lactam 
antibiotic treatment. For example, in Gram positive bacteria, β-lactamase can be 
induced directly by β-lactam antibiotics or indirectly by muropeptides that are released 
from PG after β-lactam treatment (55). In Gram-negative bacteria (e.g., 
Enterobacteriaceae), muropeptide produced after β-lactam treatment can also induce 
the expression β-lactamase(56, 84). In addition to β-lactam treatment, β-lactamase 
expression in Gram-negative bacteria can also be induced by the changes of growth 
rate (58, 85). The direct role of β-lactam in inducing the expression of β-lactamase in 
Gram-negative bacteria has not been reported.  
 
Two-component systems (TCSs), which are typically composed of a sensor histidine 
kinase (HK) and a response regulator (RR), are widely present in many bacterial 
species (86, 87). Typically, environmental signals are sensed by histidine kinase, 
leading to its autophosphorylation and subsequent phosphoryl transfer to its cognate 
response regulator (69, 88). Upon phosphorylation, a response regulator usually 
controls the expression of genes for adaptation to changing environment. Certain TCSs 
have been shown to contribute to antibiotic (e.g., glycopeptide) resistance. For example, 
VanS, the histidine kinase of VanSR TCS, directly binds to vancomycin, eading to the 
expression of genes that are required for the synthesis of alternate peptidoglycan 
precursors that have low affinity for vancomycin (80, 81, 89). TCSs (e.g., 
BlrAB in Aeromonas or CreBC in Escherichia coli and Pseudomonas) have also been 
shown to be involved in the expression of β-lactamase and thus are important for β-
lactam resistance (3, 9, 18). The response regulator of BlrAB or CreBC triggers the 
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expression of β-lactamase by recognizing the signature sequences (cre/blr-tag: 
TTCACnnnnnnTTCAC) located in the promoter of β-lactamase gene (48, 85, 90). 
Despite the evidence that TCS plays an important role in the induction of β-lactamase 
expression, the identity of the cues that are recognized and transmitted by TCS to 
control β-lactamase expression remain completely unknown (91).  
 
Here, we reported a previously unidentified mechanism that governs β-lactamase 
production in Gram-negative bacterium Vibrio parahaemolyticus, the leading cause of 
seafood-borne diarrheal disease worldwide. Most isolates of V. parahaemolyticus from 
both clinical and environmental settings exhibit resistance to β-lactam antibiotics, 
thereby limiting treatment options. At the time we initiated these studies, there was 
minimal knowledge of the mechanisms underlying V. parahaemolyticus resistance to β-
lactam antibiotics. However, a recent report revealed that essentially all V. 
parahaemolyticus isolates encode a class A chromosomal carbenicillin-hydrolyzing 
(CARB) β-lactamase (blaV110) (92). We independently identified this chromosome II-
encoded enzyme as part of the regulon of a novel TCS (VbrK/VbrR) that controls V. 
parahaemolyticus resistance to β-lactam antibiotics. Notably, we show that the sensor 
histidine kinase, VbrK, in this system detects β-lactam antibiotics via direct binding and 
transmits the signal to the response regulator, VbrR, to control the expression 
of this CARB β-lactamase gene. 
  
2.2 Materials and methods 
2.2.1 Strains and plasmids 
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All E. coli strains were cultured in Lysogeny broth (LB) at 37 °C. WT V. 
parahaemolyticus RIMD2210633 (10) was grown in LB containing 1% NaCl or in the M9 
minimum medium. All deletion mutants were generated by allelic exchange using the 
suicide vector pDM4. Complementation was conducted by cloning the respective genes 
in the low-copy (approximately seven copies per cell) vector pMMB207. The strains and 
vectors used in this study are listed in Table 1. Primers used in this study are listed in 
Table 2.  
 
2.2.2 Construction of the deletion knockouts  
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2.2.2.1 Construction of the pDM4 based plasmid 
 
All pDM4 based knockouts were generated by homologous recombination. The flanking 
regions (300-500bp) of target gene were amplified by PCR. The primers for amplifying 
upstream fragment are named gene number _1F and gene number _1R; the primers for 
amplifying downstream fragment are named gene number _2F and gene number _2R. 
Primers 1F and 2R included overlap sequences to pDM4 vector at their 5’ and 3’ end 
respectively. Primers 1R and 2F included complimentary sequences at their 3’ and 5’ 
end. PCR reactions were carried out in 2X master mix (Thermo Scientific) that include 
Taq DNA Polymerase, dNTPs, and all of the components required for PCR, except DNA 
template and primers. The PCR reaction mixture was treated for 5min at 95°C, followed 
by 30 cycles of 30s at 94°C, 30s at 55°C, 45s at 68°C, the reaction was ended with 5 
min at 68°C. Products were examined on a 0.8% (w/v) agarose gel and purified with the 
QIAquick-spin PCR purification kit (Qiagen). The purified DNA fragments were ligated 
into XhoI-digested pDM4 through isothermal assembly cloning. The cloning system 
include 5% PEG-8000, 100mM Tris-HCl (Ph7.5), 10mM MgCl2, 10mM DTT, 200uM 
each dNTP, 1mM NAD, 20ng pDM4, and 100ng DNA fragments. The mixture was 
incubated at 50°C for 60min.  
Plasmids pDM4-HK1-32. The up- and downstream regions flanking 31 potential 
histidine kinase genes (the ORF number is shown in Fig. S1) were amplified using 
primer pairs (Table 2.2). V. parahaemolyticus RIMD 2210633 chromosomal DNA was 
used as a template. The resulting product was inserted into XhoI-digested pDM4, 
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resulting in plasmids of pDM4-HK1-32 (Table 2.1). These plasmids were used to 
construct the deletion mutants lacking 31 histidine kinases shown in Fig.2-1 .  
Plasmid pDM4-19. The up- and downstream regions flanking vpa0919 (vbrR) were 
amplified using primer pairs VPA0919_1F/ VPA0919_1R and 
VPA0919_2F/VPA0919_2R, respectively. The resulting product was inserted into XhoI-
digested pDM4, resulting in plasmid pDM4-19 (Table 2.1). This plasmid was used to 
generate vbrR deletion mutant.  
Plasmid pDM4-0477. The up- and downstream regions flanking vpa0477 (blaA) were 
amplified using primer pairs VPA0477_1F/ VPA0477_1R and 
VPA0477_2F/VPA0477_2R, respectively. The resulting product was inserted into XhoI-
digested pDM4, resulting in plasmid pDM4-0477 (Table 2.1). This plasmid was used to 
generate the blaA deletion mutant 
 
2.2.2.2 Construction of deletion mutants 
Deletion mutants were generated by homologous recombination. Take ∆VbrR (∆ 
vpa0919) as an example. The ligation product containing plasmid pDM4-19 was 
dialyzed for 15 minutes and then incubated with competent E.coli sm10 on ice for 10 
minutes. The mixture was transferred into cuvettes and electroporated at voltage of 
2kV. 1ml LB was then added to the mixture and incubated at 37°C for 1h before it was 
plated on selective LB agar supplemented with 50ug/ml chloramphenicol. The plasmid 
pDM4-19 was transferred into V. parahaemolyticus by conjugation with E.coli, resultant 
transconjugants were selected by 50ug/ml carbenicillin and 50ug/ml chloramphenicol. 
To complete the allelic exchange, the integrated suicide plasmid was induced to excise 
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from the chromosome by growing on LB containing 10% sucrose. Chloramphenicol- 
sensitive clones were obtained and screened by PCR with primers 1F and 2R. One 
clone was selected with vpa0919 gene deletion thereafter designated as ∆ vpa0919. 
Construction of other HK and blaA deletion mutants was performed in the same manner 
as described above.  
  
2.2.3 Construction of complementation strain 
2.2.3.1 Construction of plasmid for complementation  
 
Complementation was conducted by cloning the respective genes in the low-copy 
(approximately seven copies per cell) vector pMMB207.  
Plasmid pMMB207-19. The vbrR gene was amplified using primers 
VPA0919_pMMB_F and VPA0919_pMMB_R. A 6xHis tag was added at the C terminus. 
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting 
in plasmid pMMB207-19 (Table 2.1). This plasmid was used to complement ΔvbrR and 
protein expression for phosphorylation assay. 
Plasmid pMMB207-20. The vbrK gene was PCR amplified using primers 
VPA0920_pMMB_F and VPA0920_pMMB_R. A 6xHis tag was added at the C terminus. 
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting 
in plasmid pMMB207-20 (Table 2.1). This plasmid was used to complement ΔvbrK and 
protein expression for phosphorylation assay. 
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Plasmid pMMB207-20-H286A. Point mutation H286A was introduced in the coding 
sequence of vbrK by PCR using primer pairs VPA0920_pMMB_F/VPA0920H286A_1R 
and VPA0920- 
H286A_2F/VPA0920 pMMB_R, respectively. A 6xHis tag was added at the C terminus. 
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting 
in plasmid 
pMMB207-20-H286A (Table 2.1). This plasmid was used to express VbrKH286A protein. 
Plasmid pMMB207-19-D51A. Point mutation D51A was introduced in coding sequence 
of vbrR by PCR amplification from V. parahaemolyticus using primer pairs 
VPA0919_pMMB_F/VPA0919- D51A_1R and VPA0919D51A_2F/VPA0919_pMMB_R, 
respectively. A 6xHis tag was added at the C terminus. The PCR product was inserted 
into BamHI, XbaI double-digested pMMB207, resulting in plasmid pMMB207-19-D51A. 
This plasmid was used to express VbrRD51A protein. 
 
Plasmid pMMB207-0477. The gene for blaA was PCR amplified from V. 
parahaemolyticus using primers VPA0477_RBS_pMMb_F and VPA0477_pMMB_R. 
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting 
in plasmid pMMB207- 0477 (Table 2.1). This plasmid was used to complement ΔblaA. 
 
2.2.3.2 Construction of complementation strain 
Constructed vectors were cloned into E.coli sm10 and conjugated into corresponding 
knockout mutants as described above. Resultant complementation strain were selected 
with 50ug/ml carbenicillin and 50ug/ml chloramphenicol.  
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2.2.4 Cloning of mutated and truncated VbrK proteins into expression plasmid  
Plasmid pGEX-0920SD. The coding sequence for hypothetical sensor domain (amino 
acids 25–240) of VbrK was PCR amplified from V. parahaemolyticus using primers 
920SD_GST_FBamHI and 920SD_GST_RXhoI. The resulting PCR product was 
digested with BamHI or XhoI, accordingly, and inserted into the equivalentsite of 
plasmid pGEX, resulting in plasmid pGEX-0920SD (Table 2.1). This plasmid was used 
to express the GST-tagged sensor domain of VbrK. 
Plasmids pGEX-0920-L82A, pGEX-0920-L95A, and pGEX-0920-P125A. The point 
mutation L82A/L95A/P125A was introduced into VbrK by PCR amplification using 
primer pairs 920SD_GST_FBamHI/920L82A_1R and 
920SD_GST_RXhoI/920L82A_2F, 920SD_GST_FBamHI/ 
920L95A_1R and 920SD_GST_RXhoI/920L95A_2F, and 
920SD_GST_FBamHI/920P125A_1R and 920SD_GST_RXhoI/ 920P125A_2F, 
respectively (Table 2.2). A 6xHis tag was added at the C terminus of each mutant. The 
resulting PCR products were digested with BamHI or XhoI, accordingly, and inserted 
into the equivalent site of plasmid pGEX, resulting in plasmids pGEX- 
0920-L82A, pGEX-0920-L95A, and pGEX-0920-P125A (Table 2.1). These plasmids 
were used to express GST-VbrKL82A, GSTVbrKL95A, and GST-VbrKP125A. 
 
2.2.5 Preparations for RNA-sequencing and RNA-seq analysis 
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RNA-seq was performed as described in (93). Bacteria were grown in LB supplemented 
with 50 μg/mL carbenicillin for 3 h. Total RNA was isolated by RNEasy kit (Qiagen) 
according to the manufacturer’s instruction. RNA samples were treated with DNase, 
followed by the removal of rRNA using the RiboZero kit for Gram-negative bacteria 
(Epicentre). Bacterial mRNA was fragmented to yield fragments in the range of 60–200 
nt. The fragmented RNA and random primers were used for the synthesis of first-strand 
cDNA. Second strand cDNA was synthesized subsequently. Libraries for Illumina 
sequencing were generated by adding Illumina-specific adaptors to cDNA. Reads from 
Illumina sequencing were aligned to chromosomes I and II of V. parahaemolyticus. The 
total number of reads that can be aligned to the genome was calculated. Subsequently, 
total reads per gene were normalized by RPKM [(reads/kb of gene)/(million reads 
aligning to genome)] (94). DEseq, a program that was developed to analyze the 
statistical differences in gene expression (95) was used to identify differentially 
expressed genes between WT and ΔVbrK strains.  
 
2.2.6 RNA extraction and RT-PCR 
Bacteria were grown in LB supplemented with or without 50 μg/mL carbenicillin for 3 h. 
Total RNA was isolated by RNEasy kit (Qiagen) according to the manufacturer’s 
instruction. RNA samples were treated with DNase at 37°C to remove any DNA 
contamination. First strand of cDNA was synthesized by SuperScript™ III First-Strand 
Synthesis System (Invitrogen), and following PCR was performed using blaA-specific 
primers (Table 2.2). and secY was used as an internal control. 
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2.2.7 β-Lactamase activity assay. 
β-Lactamase activity was quantified based on hydrolysis of nitrocefin. Bacteria were 
subcultured in LB for 3 h in the presence of carbenicillin (50 μg/mL), and an equal 
amount of bacterial cells were pelleted, resuspended in PBS, and sonicated. Cell lysate 
was incubated with 50 μg/mL nitrocefin for 30 min at room temperature before OD490 
was measured. To determine the effect of β-lactam on β-lactamase activity, bacteria 
were subcultured in M9 medium containing different concentrations of carbenicillin, and 
β-lactamase activity was quantified at different time points after carbenicillin was added. 
2.2.8 Phosphorylation assay 
Both in vivo and in vitro phosphorylation were performed using a Phos-tag SDS-PAGE. 
The Phos-tagTM added to acrylamide gel are obtained from Wako.  
In vivo phosphorylation assay 
For in vivo phosphorylation, bacterial strains harboring VbrK or VbrR vectors were 
grown 
in LB or M9 with or without treatment of carbenicillin (50 μg/mL). Following 3 h of 
treatment, whole-cell lysate was obtaining by sonication and resolved in 12% (wt/vol) 
SDS gels (29:1) containing 50 μM Phos-tag acrylamide and 100 μM MnCl2. Proteins in 
the Phos-tag gels were transferred onto a nitrocellulose membrane, and protein mobility 
shift was determined by Western blot using anti-His antibody.  
 In vitro phosphorylation assay 
For in vitro phosphorylation, E. coli DH5α harboring plasmids encoding WT or mutant 
VbrK constructs were grown in LB at 37 °C, and protein expression was induced by 1 
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mM IPTG for 3 h with shaking. Following centrifugation (5,000 x g) for 5 min, the cell 
pellet was resuspended in lysis buffer [50 mM Tris (pH 8.0), 200 mM NaCl, and 5 mM 
MgCl2], and lysed by sonication. Cell lysates were centrifuged for 30 min at 9,300 x g to 
remove the cell debris, and the cleared supernatant was ultracentrifuged at 180,000 x g 
for 1 h. Kinase buffer containing 50 mM Tris (pH 8.0), 100 mM KCl, 5 mM MgCl2, and 
10% (vol/vol) glycerol was then used to resuspend the 
membrane pellets. The membrane extracts containing WT VbrK or mutant VbrK were 
treated with carbenicillin (50 μg/mL) or left without treatment of carbenicillin. 
Subsequently, samples 
were resolved in Phos-tag gels, and protein mobility shift was determined. In vitro 
phosphorylation was also performed for VbrK membrane extracts treated with other 
lactams, including e-caprolactam, δ-valerolactam, and 2-azacyclononanone. 
 
2.2.9 Expression and purification of GST tagged protein 
A seed culture of Escherichia coliDH5αλpir harboring plasmids encoding GST-tagged 
VbrK sensor domain (GST-VbrKSD), GST-VbrKSD_L82A, or GST alone was grown 
overnight in 3 ml Lysogeny broth (LB). A 1 ml aliquot from this seed culture was used to 
inoculate 300ml LB supplemented with or without carbenicillin (50 μg/mL). The growth 
of bacteria was allowed to continue up to an OD600 0.4, then the protein expression was 
initiated with the addition of 1mM IPTG and the bacterial culture was shaken for another 
2-3 hrs at 37°C. The cells were harvested by centrifugation at 5,000 x g for 5 min and 
suspended in PBS (10 mM phosphate buffer pH 7.4, 150 mM NaCl). GST-tagged 
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proteins were purified by glutathione- agarose (Sigma-Aldrich) as per manufacturer’s 
instructions. Briefly, The soluble content of the cells was liberated via sonication, Triton 
X-100 was added to the lysate to a final concentration of 1% (v/v). Cell debris were 
removed by centrifugation at 13,000xg for 10 min at 4°C, the supernatant was incubated 
with 2.5ml PBS- equilibrated resin in the column for 2 hours at 4°C and under gravity 
flow. Resin was washed four times with PBS-T (PBS containing 1% Triton X-100) at 
4°C, and GST-tagged protein is eluted by elution buffer (5 mM to 10 mM reduced 
glutathione in 50 mM Tris-HCl, pH 7.5) 3 times, 1ml each. The fractions containing 
GST-tagged proteins were analyzed by 12% SDS-PAGE and Coomassie blue stain.  
2.2.10 Penicillin binding assay 
2.2.10.1 Penicillin binding ELISA 
 
For penicillin binding assay, purified GST - tagged proteins were coated to Polyvinyl 
Chloride(PVC) microtiter plate by mixing with bicarbonate/carbonate buffer (100 mM, pH 
9.6) for 2 h, followed by incubation with or without penicillin in phosphate buffer (20 mM 
potassium phosphate, 40 mM sodium chloride, pH 7.5) for 1 h. Mouse monoclonal anti-
penicillin antibody (Fisher Scientific) and HRP-conjugated anti-mouse IgG secondary 
antibody (diluted in1% BSA) were then added and incubated with protein for 1 h, 
sequentially. PBC was manifested by adding HRP substrate (TMB) to each well and 
measuring OD370. All incubations were carried out at room temperature and were 
followed by decanting and washing with PBS containing 0.05% Tween-20 four times 
before subsequent procedures.  
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2.2.10.2 Penicillin binding pull-down 
Pull-down assay was performed using G Sepharose beads(abcam), the steps followed 
manufacture’s instructions with minor revisions. Briefly, anti-penicillin antibody and 
penicillin was sequentially incubated with protein G Sepharose beads in PBS for 1h for 
immobilization. Subsequently, GST-VbrKSD or GST-VbrKSD_L82A were added onto 
the beads and incubated for 2 h to allow the binding between VbrK and penicillin. After 
incubation, the slurry was washed with wash buffer (10mM Tris, pH 7.4, 1mM EDTA, 
1mM EGTA; pH 8.0, 150mM NaCl, 1% Triton X100) 3 times to remove excessive 
antibody and nonspecific binding proteins. Proteins were eluted by adding 1X protein 
loading buffer (Bio-rad) analyzed by western blot using anti-GST.  
 
2.2.11 Antibiotic susceptibility testing 
Minimal inhibitory concentration(MIC) of V. parahaemolyticus to antibiotic agents was 
determined using the broth dilution method in accordance with previous guidelines (96). 
Briefly, two-fold serial dilutions of antibiotics in LB broth were made from 10mg/ml 
antibiotic stocks. The concentration of antibiotics ranges from 1-256 ug/ml. One tube 
with no antibiotic was included as a growth control. Bacteria were grown fresh and 
diluted to inoculum size of 5X 105 colony-forming units (cfu)/ml, and were incubated in 
the presence of antibiotics overnight (18 hours) at room temperature. The MIC was 
defined as the lowest concentration of antibiotic that completely inhibited visual growth 
of the bacteria. 32ug/ml is considered as a general borderline of antibiotic resistance 
according to previous criteria(97).  
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2.3 Results 
2.3.1 V. parahaemolyticus RIMD 2210633 is resistant to multiple antibiotics 
12 antibiotics belonging to 9 categories including β-lactam, macrolide, glycopeptide, 
aminoglycoside, antimicrobial peptide, fluoroquinolones and tetracyclines were tested. 
Based on the guideline that 32ug/ml is a borderline for antibiotic resistance (97), V. 
parahaemolyticus were determined to be resistant to 7 antibiotics tested. MICs toward 
these antibiotics are as follows: strepytomycin(64ug/ml), kanamycin (32ug/ml), 
erythromycin (64ug/ml), vancomycin (256ug/ml), polymyxinB(32ug/ml), 
carbenicillin(>256ug/ml), ampicillin(>256ug/ml) and spectiomycin (128ug/ml). 
 
2.3.2 Identification of a Histidine Kinase That Is Essential for V. parahaemolyticus 
Resistance to β-Lactams. 
V. parahaemolyticus isolated from both environmental and clinical settings are routinely 
resistant to β-lactam antibiotics. As part of an ongoing project to characterize the roles 
of V. parahaemolyticus’ TCSs, we attempted to delete all 32 of thepredicted histidine 
kinases encoded in the pathogen’s genome. 31 mutants were successfully created, 
each containing a deletion of an individual ORF encoding a putative histidine kinase. 
Notably, it was found that one of the mutants, harboring a deletion of vpa920, could not 
grow on LB agar plates containing carbenicillin (Fig.2-1A), ampicillin, or penicillin (Fig. 
2-1B). Complementation of the 
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Δvpa0920 mutant with a wild-type vpa0920 in trans restored resistanceto carbenicillin 
(Fig. 2-1C), indicating that vpa0920 is important for carbenicillin resistance. These 
results indicate that the predicted histidine sensor kinase vpa0920 (now designated as 
VbrK for Vibrio β-lactam resistance sensor kinase) is essential for V. parahaemolyticus 
β-lactam resistance. VbrK is composed of 484 aa, of which amino acids 14–275 contain 
the domain of DUF3404 with unknown functions. The region encompassing amino acids 
274–332 is predicted to be the histidine kinase (HisKA) domain, and the region from 
amino acids 390–475 is the ATPase 
domain. VbrK is present in all Vibrio species with 60–90% sequence identity across the 
species. VbrK is predicted to be a membrane protein with two potential transmembrane 
regions located at amino acids 9–16 and amino acids 240–260, respectively (Fig. 2-2A). 
Amino acids 25–240 are predicted to be located extracellularly, whereas amino acids 
261–484 are predicted to be located intracellularly. We expressed VbrK with a C-
terminal 6xHis tag in ΔvbrK, and our results showed that VbrK_6xHis was exclusively 
present in the membrane extracts (Fig. 2-2B), experimentally demonstrating that VbrK is 
a membrane protein. In the downstream of vbrK, there is an ORF (vpa0919) encoding 
predicted response regulator (designated as vbrR for Vibrio β-lactam resistance 
response regulator). As expected, VbrR_6xHis is a cytosolic protein (Fig. 2-2B).  
 
2.3.3 Identification of Genes That Are Regulated by VbrK. 
We carried out RNA sequencing (RNA-seq) experiments to identify the VbrK regulon, 
with the ultimate goal of elucidating the mechanisms by which this histidine kinase 
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regulates β-lactam resistance. In these experiments, we compared the transcriptomes 
of wild-type and ΔvbrK V. parahaemolyticus grown in LB. We found that 230 (4.9%) and 
235 (5.0%) of the 4,868 annotated V. parahaemolyticus ORFs were significantly up- and 
down-regulated (more than 
threefold), respectively, in the ΔvbrK strain compared with WT. To gain insight into the 
pathways that are regulated by VbrK, we grouped the differentially expressed genes 
based on their GO annotations. This analysis revealed that several GO categories were 
significantly reduced (more than twofold) in the ΔvbrK mutant compared with the WT, 
including those involving peptidoglycan biosynthesis, vancomycin resistance, pyruvate 
metabolism, and β-lactam resistance (Fig. 2-3 and Table 2-3). Genes in the β-lactam 
resistance category include vp0040 encoding TetR transcriptional factor, vp0039 
encoding HlyD membrane fusion protein, 
vp0454 encoding penicillin binding protein 3, vp0545 encoding β-hexosaminidase, 
vp2751 encoding penicillin binding protein 1A, and vpa0477 encoding a class A β-
lactamase. The latter gene had the largest fold change (3.5 folds) between the WT and 
ΔvbrK mutant, and encodes a class A CARB β-lactamase (blaA) with 98.36% identity in 
nucleotide sequence and 98.59% 
identity in amino acid sequences to the recently described blaV110(92). We performed 
RT-PCR analyses to verify that blaA is regulated by VbrK. Notably, expression of blaA 
was dependent on 
VbrK; we observed blaA expression in the WT strain (Fig. 2-4A, lanes 1 and 2), but not 
in the ΔvbrK strain (Fig. 2-4A, lanes 3 and 4). Complementation of ΔvbrK with the WT 
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vbrK gene in trans restored the expression of blaA (Fig. 2-4A, lanes 7 and 8), indicating 
that VbrK is essential for the expression of blaA. 
 
 
 
2.3.4 VbrK Is Essential for V. parahaemolyticus β-Lactamase Activity. 
Because VbrK is critical for the expression of blaA (Fig. 2-4 A), and blaA is predicted to 
encode a β-lactamase, we hypothesized that VbrK is also essential for β-lactamase 
activity. β-Lactamase activity was determined by measuring the ability of bacterial cell 
lysate to hydrolyze the substrate nitrocefin, which rapidly changes color from yellow to 
red upon degradation. As seen in Fig. 2-4 B, lysates from WT hydrolyzed nitrocefin 
yielding a red color (Fig. 2-4 B) detectable as an increase in OD490 (Fig. 2-4C), 
whereas the lysate from the ΔvbrK mutant did not hydrolyze nitrocefin (Fig. 2-4 B), 
yielding a baseline OD490 indistinguishable from a ΔblaA mutant (Fig. 2-4C). 
Complementation of the ΔvbrK mutant with a WT vbrK gene in trans restored the 
strain’s ability to hydrolyze nitrocefin (Fig. 2-4 B and C) demonstrating that VbrK is 
essential for V. parahaemolyticus β-lactamase activity. Furthermore, deletion of blaA 
abolished β-lactamase activity (Fig. 2-4 B and C) and β-lactam resistance (Fig. 2-5). 
However, expression of blaA in the ΔvbrK mutant restored the strain’s ability to produce 
β-lactamase and resist β-lactam antibiotics (Fig. 2-4 B and C). Thus, these observations 
strongly suggest that VbrK controls β-lactam resistance via regulating the expression of 
blaA that encodes a functional β-lactamase. 
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2.3.5 Transcription of blaA and production of β-Lactamase require β-Lactam 
treatment. 
We have shown that blaA is expressed in a VbrK dependent fashion when V. 
parahaemolyticus is grown in LB containing carbenicillin (Fig. 2-4). We hypothesized 
that blaA transcription is regulated by β-lactams. To eliminate the confounding factors in 
LB, we grew WT in minimum (M9) medium with or without carbenicillin and determined 
the expression of blaA by RT-PCR. The results showed that blaA was transcribed in the 
presence of carbenicillin, whereas it was not transcribed in the absence of carbenicillin 
(Fig. 2-6A). We further showed that β-lactamase activity in WT was controlled by 
carbenicillin in a dose-dependent manner (Fig. 2-6B and Fig. 2-7A). In addition to 
carbenicillin, β-lactamase activity can also be induced by other β-lactams, including 
ampicillin and penicillin (Fig. 2-7B). We used 50 μg/mL carbenicillin in subsequent 
studies. β-Lactamase activity was gradually increased from 0 to 3 h after β-lactam was 
supplied 
(Fig. 3C and Fig. 2-7C), indicating that β-lactamase activity was controlled by 
carbenicillin in a time-dependent manner. Although β-lactamase activity is only slightly 
increased at 1 h after carbenicillin was added, such an increase was sufficient to trigger 
β-lactam resistance, because the growth curve of WT in the presence of carbenicillin 
was similar to that in the absence of carbenicillin (Fig. 2-7F), whereas cfu of ΔvbrK was 
decreased in the presence of carbenicillin (Fig. 2-7F) in the first hour of growth. These 
results suggest that carbenicillin triggers VbrK-dependent β-lactam resistance quickly 
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(as early as 10 min after carbenicillin was added). β-Lactams contain a four-ring atom 
structure, whereas other lactams contain five-ring atoms (γ-lactam), six-ring atoms (δ-
lactam), seven-ring atoms (e-lactam), and nine-ring atoms (Fig. 2-7E). We found that β-
lactamase activity was only triggered by the β-lactam, but not other lactams (Fig. 2-6D 
and Fig. 2-7D). 
 
2.3.6 VbrK Can Be Phosphorylated on Its Conserved Histidine Residue in Vivo. 
Histidine kinases usually contain a conserved histidine residue that can be 
phosphorylated, and such phosphorylation is essential for its signal transducing 
function. We determined VbrK phosphorylation using Phos-tag, which preferentially 
binds phosphorylated protein, retarding migration in SDS/PAGE gels (98). In this 
experiment, we grew bacteria in LB with or without 
carbenicillin, and whole-cell lysate was obtained for SDS/PAGE and Western blot. In the 
presence of carbenicillin, a shifted band (VbrK-P) of VbrK_6xHis was detected when 
proteins were separated in Phos-tag gel (Fig. 2-8A), indicating that VbrK was 
phosphorylated. When the conserved histidine residue at the 286th amino acid of VbrK 
was substituted with alanine (H286A), VbrK phosphorylation was abolished (Fig. 2-8A), 
indicating that VbrK phosphorylation is dependent on its conserved histidine residue. In 
the absence of carbenicillin, phosphorylation of VbrK was not detected (Fig. 2-8A). 
Furthermore, the substitution of histidine with alanine in VbrK abolished blaA expression 
(Fig. 2-4 A, lanes 9 and 10), β-lactamase activity (Fig. 2-4 B and C), and β-lactam 
 34 
resistance (Fig. 2-1C), indicating that VbrK phosphorylation is functionally important for 
V. parahaemolyticus β-lactam resistance. 
 
2.3.7 VbrK Forms a TCS with Its Response Regulator VbrR. 
Deletion of vbrR, the putative response regulator located adjacent to vbrK on the 
chromosome, abolished blaA gene expression (Fig. 2-4A, lanes 5 and 6), β-lactamase 
activity (Fig. 2-4 B and C), and β-lactam resistance (Fig. 2-1C). Complementation of 
ΔvbrR with a WT vbrR gene in trans restored the blaA gene transcription (Fig. 2-4A, 
lanes 11 and 12), β-lactamase activity (Fig. 2-4 B and C), and β-lactam resistance (Fig. 
2-1C), indicating that VbrR is essential for β-lactam resistance. Together, these 
observations strongly suggest that VbrK and VbrR form a TCS that controls cellular 
production of β-lactamase. To determine if VbrR can be phosphorylated, we expressed 
VbrR_6xHis in ΔvbrR, and phosphorylation was assessed using the Phos-tag assay. A 
shifted band of VbrR was observed when bacteria were cultured in the presence of 
carbenicillin (Fig. 2-8 B); in contrast, the shifted band was not observed in the absence 
of carbenicillin (Fig. 2-8 B), indicating that VbrR was phosphorylated in response to 
carbenicillin. More importantly, when VbrR was expressed in ΔvbrK, the shifted band of 
VbrR was not observed (Fig. 2-8 B), indicating that VbrR phosphorylation requires VbrK, 
and VbrK and VbrR form a functional TCS regulating β-lactam resistance. To determine 
if phosphorylation of VbrR is important for its function to induce β-lactamase expression, 
we substituted the conserved aspartate residue at the 51st amino acid of VbrR (a 
predicted phosphorylation site) with alanine and expressed the VbrRD51A protein in the 
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ΔvbrR strain. As expected, D51A substitution completely eliminated the phosphorylation 
of VbrR (Fig. 2-8 B). Furthermore, there was no blaA expression (Fig. 2-4A, lanes 13 
and 14), β-lactamase activity (Fig. 2-4 B and C), and β-lactam resistance (Fig. 2-1C) in 
the ΔvbrR:pVbrRD51A strain, indicating that VbrR phosphorylation by VbrK is essential 
for β-lactam resistance. 
 
2.3.8 Mutation in the Extracellular Region of VbrK Alters Its Recognition 
Specificity for Lactams. 
Because β-lactamase activity was triggered only by β-lactams (Fig. 2-6D and Fig. 2-7D), 
we determined VbrK phosphorylation under these conditions. In these experiments, we 
obtained whole-cell lysates of bacteria grown in M9 medium supplemented with different 
lactams. Phosphorylation of VbrK was observed as early as 10 min after carbenicillin 
was supplied (Fig. 2-9A). In the subsequent studies, we harvested proteins 3 h after 
carbenicillin was added to get more phosphorylated proteins. VbrK was phosphorylated 
when V. parahaemolyticus was treated with β-lactam, but not with other lactams (Fig. 2-
9B), indicating that β-lactam triggers β-lactamase expression via phosphorylation of 
VbrK. VbrK phosphorylation upon treatment 
with β-lactam does not necessary indicate that VbrK is directly responding to β-lactam; 
it is possible, e.g., that β-lactam treatment produces peptidoglycan breakdown products 
(i.e., muropeptides), which serve as the trigger for VbrK phosphorylation. To test the 
hypothesis that VbrK is a β-lactam receptor that directly detects β-lactam, we mutated 
the conserved amino acids in the extracellular region predicted to form a pocket (Fig. 2-
 36 
10) to serve as the signal recognition site. Single-mutation L82A in VbrK completely 
abolished the ability to produce β-lactamase (Fig. 2-9F and Fig. 2-11). Furthermore, 
VbrK with L82A mutation cannot be phosphorylated upon treatment with β-lactam or 
other lactams (Fig. 5C), suggesting that L82 is critical for β-lactam recognition. Notably, 
the mutant harboring VbrKL95A phosphorylated VbrK (Fig. 2-9D) and yielded 
expression of β-lactamase (Fig. 2-9F and Fig. 2-11) in response to e caprolactam and 
2-azacyclononanone in addition to carbenicillin. Similarly, the mutant harboring 
VbrKP125A phosphorylated VbrK and expression of β-lactamase (Fig. 2-9 E and F and 
Fig. 2-11) in response to δ-valerolactam as well as carbenicillin. Because e-
caprolactam, 2-azacyclononanone, and δ-valerolactam do not produce peptidoglycan 
breakdown products, but have the capacity to induce phosphorylation of VbrK 
containing amino acid substitutions in its periplasmic pocket domain (Fig. 2-9 D and E), 
it is unlikely that peptidoglycan breakdown products activate VbrK phosphorylation. 
Taken together, these findings strongly suggest that VbrK is a bona fide β-lactam 
receptor. 
 
2.3.9 VbrK Is Phosphorylated in Vitro. 
To further investigate whether VbrK is sufficient to interact with and respond (via 
autophosphorylation) to β-lactams, we isolated membrane extracts from an E. coli strain 
expressing VbrK. The membrane extracts were treated with both carbenicillin and ATP 
in vitro and VbrK phosphorylation was assessed with the Phos-tag assay. A shifted 
band of VbrK was observed when the membrane extract was treated with both 
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carbenicillin and ATP; the intensity of such a shifted band was much lower without 
carbenicillin treatment (Fig. 2-12A, lanes 4 and 5), indicating that carbenicillin directly 
triggers the phosphorylation of VbrK. Carbenicillin-dependent phosphorylation requires 
the presence of ATP (Fig. 2-12A, lane 1). Furthermore, carbenicillin did not trigger 
phosphorylation of a similar membrane extract from an E. coli strain expressing 
VbrKH286A (Fig. 2-12A, lanes 2 and 3), strongly suggesting that the conserved 
histidine residue in VbrK is required for carbenicillin to trigger the protein’s 
autophosphorylation. Treatment with other lactams did not induce the phosphorylation 
of VbrK (Fig. 2-12B). Taken together, these results reveal that VbrK phosphorylation is 
directly triggered by β-lactam, but not by other lactams. 
 
2.3.10 Extracellular Sensor Domain of VbrK Directly Binds Penicillin. 
To further elucidate the mechanisms by which β-lactam triggers the phosphorylation of 
VbrK, we determined if penicillin can directly bind to the periplasmic sensor domain of 
VbrK (amino acids 25–240, VbrKSD). We purified GST-VbrKSD, GST, and 
GSTSD_L82A to homogeneity as shown by Coomassie blue staining (Fig. 2-13). A 
microtiter plate was subsequently coated with these purified proteins, and penicillin 
binding to the precoated microtiter plate was measured using anti-penicillin antibody 
and HRP-conjugated secondary antibody. Blue color formation and increases of OD370 
indicate that penicillin binds to the microtiter plate. Addition of 50 ng penicillin to the 
wells precoated with GST-VbrKSD results in slight blue color formation and 
approximately twofold increase of OD370 compared with the wells without addition of 
 38 
penicillin (Fig. 2-12 C and D). More significant blue color and approximately fourfold 
increase in OD370 was observed when 500 ng penicillin was added (Fig. 2-12 C and 
D), indicating that penicillin directly binds the VbrK sensor domain in a concentration-
dependent manner. Such binding was specific because addition of penicillin to the wells 
precoated with purified GST alone did not result in a significant blue color and increase 
of OD370 (Fig. 2-12 C and D). Furthermore, addition of penicillin to the wells precoated 
with GSTVbrKSD_L82A did not result in an increase in OD370 (Fig. 2-12 C and D), 
indicating that L82A mutation in the sensor domain of VbrK abolished its binding with 
penicillin. To further determine the binding between penicillin and VbrKSD, we 
performed a pulldown assay in which penicillin and anti-penicillin antibody were 
immobilized into a protein G Sepharose followed by addition of GST-VbrKSD or GST-
VbrKSD_L82A. The results showed that the elution contained GST-VbrKSD but not 
GST-VbrKSD_L82A, as detected by anti-GST antibody (Fig. 2-12E), further verifying 
that the sensor domain of VbrK binds penicillin, and L82 is important for such binding. 
Coupled with the results that L82A mutation abolished VbrK phosphorylation and β-
lactamase production in response to β-lactam treatment (Fig. 2-9 C and F), we 
concluded that β-lactam triggers the phosphorylation of VbrK by directly binding to the 
sensor domain of VbrK.  
 
2.4 Discussion 
In this study, we show that histidine kinase VbrK is a β-lactam receptor that triggers the 
expression of β-lactamase in response to β-lactam antibiotics in a Gram-negative 
bacterium V. parahaemolyticus. This conclusion was supported by the results that (i) 
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deletion of VbrK or its response regulator VbrR greatly reduced the expression of β-
lactamase and abolished the β-lactam resistance; (ii) VbrK activation is specifically 
triggered by β-lactam antibiotics, but not other lactam; and (iii) single amino acid 
substitution in the predicted sensor domain of VbrK alters its specificity to lactams. 
Based on these results, we propose a model in which the membrane- associated 
histidine kinase VbrK directly binds β-lactam antibiotics, leading to the VbrK 
phosphorylation, phosphoryl transfer to VbrR, and, ultimately, the expression of β-
lactamase (Fig. 2-12F).  
 
In Gram-positive bacteria (e.g., Staphylococcus aureus and Bacillus lichenformis), β-
lactam resistance is mediated by the expression of β-lactamase (blaZ) or the production 
penicillin binding protein 2a (PBP2a or MecA), which has low affinity for β-lactam 
antibiotics(99-102). Expression of blaZ is initiated upon the direct interaction of β-lactam 
with the membrane-associated β-lactam receptor (BlaR1). Here, we show that Gram-
negative bacterium, V. parahaemolyticus, uses a novel β-lactam receptor VbrK to 
induce the expression of β-lactamase. Although both BlaR1 and VbrK are membrane 
associated and recognize β-lactam via direct binding, the subsequent signaling pathway 
for β-lactamase expression is different. Upon binding to the β-lactam, BlaR1 becomes 
irreversibly acylated, which results in the autoproteolytic cleavage within the cytoplasmic 
domain of BlaR1. The cleaved form of BlaR1 is an active metalloprotease and can 
inactivate the repressor BlaI, leading to the dissociation of BlaI from the promoter of 
blaZ and consequent expression of blaZ (103, 104). In contrast, VbrK becomes 
autophosphorylated upon binding to β-lactams. The phosphoryl group is subsequently 
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transferred to the response regulator VbrR to control the expression of β-lactamase. 
When we screened for VbrK mutants that can detect other lactams, we identified P125A 
and L95A. These two substitutions may modify the β-lactam binding pocket to allow for 
the recognition of other lactams, leading to the subsequent VbrK phosphorylation, 
phosphoryl transfer to the VbrR, and production of β-lactamase. We also identified L82A 
mutation that abolished the ability of VbrK to bind to β-lactam and induce the expression 
of β-lactamase, suggesting that L82 is critical for VbrK binding to β-lactam. Alternatively, 
L82A mutation may alter appropriate protein folding, leading to an inactive VbrK. β-
Lactam binding to the pocket of VbrK may result in a conformational change that is 
transmitted to the HisKA domain, leading to a closer association with the ATPase 
domain and consequent phosphorylation of the histidine residue.  
 
β-Lactamase in Gram-negative bacteria is often induced by the β-lactam-associated 
perturbation of cell wall integrity(56) . In Enterobacteriaceae, this induction mechanism 
is complex and involves multiple proteins and steps (56, 57). β-Lactam antibiotics 
disrupt the murein biosynthesis, leading to the accumulation of muropeptides in the 
periplasm. These muropeptides can be transported through the inner membrane 
channel created by a membrane protein AmpG. Within the cytoplasm, muropeptides 
bind the transcriptional factor AmpR, and such binding activates AmpR’s DNA binding 
activity, leading to the transcription and expression of AmpC β-lactamase (105). It is 
conceivable that such multistep defensive mechanisms occur at the cost of damages in 
the cell wall integrity. Here, we provide evidence that Gram-negative bacterium V. 
parahaemolyticus can use a histidine kinase VbrK to directly sense β-lactam antibiotics, 
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leading to the production of β-lactamase. Direct sensing of β-lactam antibiotic to induce 
the expression of β-lactamase could occur potentially in a rapid fashion and at no cost 
of damages in the cell wall integrity, which may represent a novel mechanism to defend 
against β-lactam antibiotics.  
 
Although TCSs are present in a wide range of bacterial species, and their function in the 
recognition and transduction of environmental signals has been well documented, very 
few physiological signals for the histidine kinases are known. Particularly, there is only 
one antibiotic, vancomycin, that has been reported to be the signal molecule for the 
histidine kinase VanS (81, 82). Because of the lack of the defined signals that histidine 
kinase can recognize, structural analyses of ligand–histidine kinase interactions are 
very limited (87, 106, 107). Defining the ligand, β-lactam, as the signal molecule for the 
histidine kinase VbrK provides molecular tools to study the structure–activity 
relationship of VbrK and the mechanisms by which histidine kinase is phosphorylated 
and activated. Importantly, VbrK is present in almost all Vibrio species, and the residues 
(L82, L95, and P125) that are responsible for specific recognition of lactams are 
conserved in different Vibrio species (Fig. 2-14). The gene encoding β-lactamase was 
also found in many Vibrio species, including non-O1/non-O139 Vibrio cholerae, Vibrio 
harveyi, and Vibrio alginolyticus(108, 109). These results suggest that direct recognition 
of β-lactam antibiotic by VbrK is a well-conserved mechanism to induce β-lactamase 
gene expression in Vibrio species. Application of β-lactamase inhibitors could potentially 
reduce the prevalence of β-lactam resistance (110, 111). However, the inhibitors exhibit 
variable affinity to different β-lactamases, and the efficacy may be compromised by the 
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overwhelming quantity of β-lactamases they produced. Defining the VbrK/VbrR 
regulatory pathway that controls the expression of β-lactamase would provide a 
promising target to inhibit β-lactamase production and β-lactam resistance. Lead 
compounds that can inhibit the activity of histidine kinase have been identified for a 
number of TCSs (112-115). There is future promise in rationally designing VbrK 
inhibitors to enhance the efficacy of β-lactam antibiotics in treating infections caused by 
Vibrio species. 
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TABLES 
 
Table 2.1 Strains and plasmids 
Strains Relevant 
genotype/description 
Source 
Vibrio parahaemolyticus 
RIMD 2210633 
Clinical isolate (10) 
ΔvbrK RIMD 2210633 
Δvpa0920 
This work 
ΔvbrR RIMD 2210633 
Δvpa0919 
This work 
ΔblaA RIMD 2210633 
Δvpa0477 
This work 
ΔvbrK:pvbrK ΔvbrK complemented 
with vbrK gene located in 
pMMB207 
This work 
ΔvbrR:pvbrR ΔvbrR complemented 
with vbrR gene located in 
pMMB207 
This work 
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ΔblaA:pblaA ΔblaA complemented 
with blaA gene located in 
pMMB207 
This work 
ΔvbrK:pblaA ΔvbrK containing blaA 
gene located in 
pMMB207 
This work 
ΔvbrK:pvbrR ΔvbrK containing vbrR 
gene located in 
pMMB207 
This work 
ΔvbrK:pvbrKH286A ΔvbrK complemented 
with mutated vbrK 
gene(H286A) located in 
pMMB207 
This work 
ΔvbrR:pvbrRD51A ΔvbrR complemented 
with mutated vbrR 
gene(D51A) located in 
pMMB207 
This work 
Escherichia coli 
SM10λpir 
KmR, thi-1, thr, leu, tonA, 
lacY, supE, recA::RP4-2-
Tc::Mu, λpir 
This work 
Escherichia coliDH5αλpir supE44, 
ΔlacU169(ΦlacZΔM15), 
This work 
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recA1, endA1, hsdR17, 
thi-1, gyrA96, relA1, λpir 
 
Plasmids   
pDM4-19 Plasmid for deletion of 
vpa0919 
This work 
pDM4-20 Plasmid for deletion of 
vpa0920 
This work 
pDM4-0477 Plasmid for deletion of 
vpa0477 
This work 
pDM4-TCS Plasmid for deletion of 
TCS genes 
This work 
pMMB207-19 RBS and vpa0919 
sequences cloned into 
pMMB207 
This work 
pMMB207-20 vpa0920 sequence 
cloned into pMMB207 
This work 
pMMB207-0477 RBS and vpa0477 
sequences cloned into 
pMMB207 
This work 
pMMB207-19His RBS and vpa0919 
sequences with 6His 
This work 
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amino acid sequences 
cloned into pMMB207  
pMMB207-20His vpa0920 sequences and 
6His amino acid 
sequences cloned into 
pMMB207 
This work 
pMMB207-20-H286A vpa0920 sequences with 
a point mutation in 
histidine 286 and 
sequences for 6His 
amino acid cloned into 
pMMB207 
This work 
pMMB207-19-D51A vpa0919 sequences with 
a point mutation in 
aspartic acid 51 and 
sequences for 6His 
amino acid cloned into 
pMMB207 
This work 
pGEX-0920SD Sequences of vpa0920 
sensor domain cloned 
into pGEX 
This work 
pGEX-0920-L82A Sequences of vpa0920 
with a point mutation in 
This work 
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leucine 82 cloned into 
pGEX 
pGEX-0920-Y71A Sequences of vpa0920 
with a point mutation in 
tyrosine 71 cloned into 
pGEX 
This work 
pGEX-0920-L95A Sequences of vpa0920 
with a point mutation in 
leucine 95 cloned into 
pGEX 
This work 
pGEX-0920-P125A Sequences of vpa0920 
with a point mutation in 
proline 125 cloned into 
pGEX 
This work 
 
 
 
Table 2.2 Primers used in this study 
Primer name  Sequence (5’-3’) 
VPA0149_1F GCTTATCGATACCGTCGACCCTCGATGAAAGCGCGCTGCAGTA
C 
VPA0149_1R CGACTTGAACTGCGATGCCTGGCGCCCACAGATTCTAAATAAC 
 48 
VPA0149_2F CAGGCATCGCAGTTCAAGTCGCGGGTAACAATGAAGTGAACTC
G 
VPA0149_2R CACTAGTGACGCGTACTCGAAGAAACGTTCACGGTTACGGC 
VPA0710_1F GCTTATCGATACCGTCGACCCTCGACTTCTTCTTCGCTGATCA
AAC 
VPA0710_1R CGACTTGAACTGCGATGCCTGACTATCTAATTTGTCTACTCCG
C 
VPA0710_2F CAGGCATCGCAGTTCAAGTCGTGGATTTAAAACAGAGCTCAGG 
VPA0710_2R CACTAGTGACGCGTACTCGACACTTGAGGTAATTAAAGCGGC 
VPA0736_1F GCTTATCGATACCGTCGACCCTCGAACGAACCCAGGAGAAGG
TTG 
VPA0736_1R CGACTTGAACTGCGATGCCTGAAATGCTTCCTCTAATTGGAAA
G 
VPA0736_2F CAGGCATCGCAGTTCAAGTCGTGTGATGGTGATTGATGACC 
VPA0736_2R CACTAGTGACGCGTACTCGACAAGCACCTCTCCACTTTG 
VPA0763_1F GCTTATCGATACCGTCGACCCTCGAGCAGCTGCAATCATCCAA
ATC 
VPA0763_1R CGACTTGAACTGCGATGCCTGGATAGGATTCCAAGAAATGACT
TG 
VPA0763_2F CAGGCATCGCAGTTCAAGTCGTAAAAGTAGTCATAGTGGAAGA
TG 
VPA0763_2R CACTAGTGACGCGTACTCGACGGAACATAAAAGGATCTAAGC 
 49 
VPA0920_1F GCTTATCGATACCGTCGACCCTCGAATGGTCTAGTAGTTCATC
ACG 
VPA0920_1R CGACTTGAACTGCGATGCCTGGGACGATAAAAACTTGGCTG 
VPA0920_2F CAGGCATCGCAGTTCAAGTCGACTGTTACCGTTACTTGTTTC 
VPA0920_2R CACTAGTGACGCGTACTCGATCTGCCTGGTCACATGAACG 
VPA0965_1F GCTTATCGATACCGTCGACCCTCGAAAGCACGCACAGGCTTG
C 
VPA0965_1R CGACTTGAACTGCGATGCCTGTAAAAGGACTCTTGAGAGAATA
G 
VPA0965_2F CAGGCATCGCAGTTCAAGTCGCTCAAGATGTTTGGATTTTTAC
G 
VPA0965_2R CACTAGTGACGCGTACTCGAATAGGGATCAGAGCGCCAC 
VPA1075_1F GCTTATCGATACCGTCGACCCTCGACAGATACCAAGGAACACG
AG 
VPA1075_1R CGACTTGAACTGCGATGCCTGCGTCCAAATTTGCCAATGAAG 
VPA1075_2F CAGGCATCGCAGTTCAAGTCGGAATAGTCTCTAATCGTGATTC 
VPA1075_2R CACTAGTGACGCGTACTCGACTGGCGTTGTTGGAAGATAAC 
VPA1100_1F GCTTATCGATACCGTCGACCCTCGATTTTCATGCGCCATGTGG
TG 
VPA1100_1R CGACTTGAACTGCGATGCCTGAGTGGCTGTTCGCTCATTTC 
VPA1100_2F CAGGCATCGCAGTTCAAGTCGTTTCCAGCACCTCTAAAATTAC 
VPA1100_2R CACTAGTGACGCGTACTCGAGTTTAAACGCGCTGGAAACC 
 50 
VPA1130_1F GCTTATCGATACCGTCGACCCTCGAATACGCTGTTTGATATGG
GATG 
VPA1130_1R CGACTTGAACTGCGATGCCTGTGCTTTTGTGAATCGTACTTGG 
VPA1130_2F CAGGCATCGCAGTTCAAGTCGCGCCCACTTATCTCGAAATG 
VPA1130_2R CACTAGTGACGCGTACTCGATATTACAGGGATTATTGTGGCG 
VPA1277_1F GCTTATCGATACCGTCGACCCTCGAAGATTTGATGCTGCCGGG
C 
VPA1277_1R CGACTTGAACTGCGATGCCTGTTATGCGTTCCATGCATCCG 
VPA1277_2F CAGGCATCGCAGTTCAAGTCGCGGGCGAACAACGATAAAAG 
VPA1277_2R CACTAGTGACGCGTACTCGACGAGAGCTTGTGTTTTGGTG 
VPA1433_1F GCTTATCGATACCGTCGACCCTCGAAGTTTTCCCGGCTTGAGA
ATC 
VPA1433_1R CGACTTGAACTGCGATGCCTGGTTACAAAGTTTTAGTCGTGGA
C 
VPA1433_2F CAGGCATCGCAGTTCAAGTCGCCAAAATTCGATGCAGAAAC 
VPA1433_2R CACTAGTGACGCGTACTCGATTGATCATGGACGAAGCAAC 
VPA1515_1F GCTTATCGATACCGTCGACCCTCGATGCCGGACTACATGGCTT
TC 
VPA1515_1R CGACTTGAACTGCGATGCCTGGAAGTGTGAATCAGACAGATC 
VPA1515_2F CAGGCATCGCAGTTCAAGTCGCCTATCGCCTCCTCACAC 
VPA1515_2R CACTAGTGACGCGTACTCGATTGCGTCAACGGCAAGATTG 
VPA1664_1F GCTTATCGATACCGTCGACCCTCGATTTTGCTCAGCAAGCTCC
ATG 
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VPA1664_1R CGACTTGAACTGCGATGCCTGGACTATGAACAAACTGGCATTC 
VPA1664_2F CAGGCATCGCAGTTCAAGTCGAAGGGAGGGTTTGAAAGAAAG 
VPA1664_2R CACTAGTGACGCGTACTCGACGATGCCGACCCGTTTGAAC 
VP0362_1F GCTTATCGATACCGTCGACCCTCGAATTATGTTGCCTAAACTC
GATGG 
VP0362_1R CGACTTGAACTGCGATGCCTGGACTCTCTTCGAGTTTGTAGC 
VP0362_2F CAGGCATCGCAGTTCAAGTCGAAGGCAAACCTTGGCTTGCC 
VP0362_2R CACTAGTGACGCGTACTCGATTTGAAAGCAGTGGCCTGGC 
VP0487_1F GCTTATCGATACCGTCGACCCTCGATTCTTCAGACTGCGTGGC
TC 
VP0487_1R CGACTTGAACTGCGATGCCTGTCACTACTCCATGGCACAAG 
VP0487_2F CAGGCATCGCAGTTCAAGTCGCATGAAGAAACTTGCACCCG 
VP0487_2R CACTAGTGACGCGTACTCGATGGTGACTTAGAAGACTAATTC 
VP1069_1F GCTTATCGATACCGTCGACCCTCGAATCGTACAACATGGTAAG
AGAG 
VP1069_1R CGACTTGAACTGCGATGCCTGATCTGTAGACGAATCATTCCC 
VP1069_2F CAGGCATCGCAGTTCAAGTCGTATACAGGTAAAAAAGCAGTCC 
VP1069_2R CACTAGTGACGCGTACTCGACGGCATGACGAATACAAAATG 
VP1201_1F GCTTATCGATACCGTCGACCCTCGAGCAGCAGCATCCACTATT
AC 
VP1201_1R CGACTTGAACTGCGATGCCTGCACCTACATCAAATGTTGTCC 
VP1201_2F CAGGCATCGCAGTTCAAGTCGTCTTTGTCCACTTTATATCGTTG 
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VP1201_2R CACTAGTGACGCGTACTCGAATAGTGCGAAGCGAAACACAC 
VP1211_1F GCTTATCGATACCGTCGACCCTCGATTCAGGCTTGTCCATTTG
G 
VP1211_1R CGACTTGAACTGCGATGCCTGAACGAATCACTAAAGACTCTTT
TTC 
VP1211_2F CAGGCATCGCAGTTCAAGTCGTCAGTTGATACCCTAAGCC 
VP1211_2R CACTAGTGACGCGTACTCGAGACGCGATTGTGCTCGAC 
VP1375_1F GCTTATCGATACCGTCGACCCTCGATCGCCTTATGTGGTGCTA
TTC 
VP1375_1R CGACTTGAACTGCGATGCCTGTACATGTATTACCCAATATGCC 
VP1375_2F CAGGCATCGCAGTTCAAGTCGAGAACCGTTGAATAAATGGCTG 
VP1375_2R CACTAGTGACGCGTACTCGACGAAACAGAACGTGGCTGTG 
VP1503_1F GCTTATCGATACCGTCGACCCTCGATACCGTTTAAACGTTCTG
AAAATTG 
VP1503_1R CGACTTGAACTGCGATGCCTGATCCCTCATCCTCAGAATCC 
VP1503_2F CAGGCATCGCAGTTCAAGTCGCGTAAACCAACGCCAGTTCC 
VP1503_2R CACTAGTGACGCGTACTCGATCATAAAGGTTGATTTACCACAA
C 
VP1712_1F GCTTATCGATACCGTCGACCCTCGAGCTTCACCAACAAACAAG
TCG 
VP1712_1R CGACTTGAACTGCGATGCCTGACATGGCAACGCGAGTGATG 
VP1712_2F CAGGCATCGCAGTTCAAGTCGGGTACATCCTTACCGTTAACC 
VP1712_2R CACTAGTGACGCGTACTCGACCAAATTGCCTGACTTCAATG 
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VP1735_1F GCTTATCGATACCGTCGACCCTCGAGCGTTCACTGCCGTAATT
TTG 
VP1735_1R CGACTTGAACTGCGATGCCTGGAATGTTTTTGATGGCGACG 
VP1735_2F CAGGCATCGCAGTTCAAGTCGCGAAAAAAGACGACTAAAAAGG 
VP1735_2R CACTAGTGACGCGTACTCGACAAGAATCCATAGCCCAGCG 
VP1908_1F GCTTATCGATACCGTCGACCCTCGACGTCGCGATTTTCTTACT
GC 
VP1908_1R CGACTTGAACTGCGATGCCTGTGTGGTGATCGTCGATGATC 
VP1908_2F CAGGCATCGCAGTTCAAGTCGCCTTCCCTCCATGAAACGC 
VP1908_2R CACTAGTGACGCGTACTCGAGCGTTTACGTATACAGGCGG 
VP1968_1F GCTTATCGATACCGTCGACCCTCGAGGTATGAGATTTTGCCCT
TG 
VP1968_1R CGACTTGAACTGCGATGCCTGGTTCATTCACCTGCGTATTTTG 
VP1968_2F CAGGCATCGCAGTTCAAGTCGTTGGCATTAAAACTGCTTAACT
G 
VP1968_2R CACTAGTGACGCGTACTCGAGTGAATAGCTCAAGGGATTTG 
VP1984_1F GCTTATCGATACCGTCGACCCTCGACATGCTGCCGCGCATGG 
VP1984_1R CGACTTGAACTGCGATGCCTGGCACCCGGCTCCAAGC 
VP1984_2F CAGGCATCGCAGTTCAAGTCGTTGCGATGCCGATTCCGACT 
VP1984_2R CACTAGTGACGCGTACTCGATATTGTTGAGCAGATGGTGG 
VP2010_1F GCTTATCGATACCGTCGACCCTCGAATTGCAATGCACAGCTCA
TCC 
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VP2010_1R CGACTTGAACTGCGATGCCTGCTAATCGGTATTTAGGAGCAG 
VP2010_2F CAGGCATCGCAGTTCAAGTCGTCCTTGCAGATATTCTTGTTCA
G 
VP2010_2R CACTAGTGACGCGTACTCGAATTGGCGCTTGGTTTTCAATAC 
VP2478_1F GCTTATCGATACCGTCGACCCTCGAACGGTTTGTCTGGTCGCG 
VP2478_1R CGACTTGAACTGCGATGCCTG 
GGATAAGATTACAACTCGTAAAG 
VP2478_2F CAGGCATCGCAGTTCAAGTCG 
ACCTCTCATAAAATACAAGCCTC 
VP2478_2R CACTAGTGACGCGTACTCGA GCGCTGAAAGCGTTAATTAATC 
VP2567_1F GCTTATCGATACCGTCGACCCTCGAGTCAATTGTTGGTCATAA
TTGAG 
VP2567_1R CGACTTGAACTGCGATGCCTGGTTATCTAATTACATCGGAGTC 
VP2567_2F CAGGCATCGCAGTTCAAGTCGGCATTCGGACTAAACTTCATAC 
VP2567_2R CACTAGTGACGCGTACTCGAAGTCTGTGGCAGAGATGAAAG 
VP2859_1F GCTTATCGATACCGTCGACCCTCGAGAAACGCTGAAGCGTCTG
C 
VP2859_1R CGACTTGAACTGCGATGCCTGTAATCCTCCTCAAGCAGCATAT
A 
VP2859_2F CAGGCATCGCAGTTCAAGTCGCTCTACAAGATTTCAGTTGATA
ATG 
VP2859_2R CACTAGTGACGCGTACTCGAGTCTTTGAACTTTTCGAAGTG 
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VPA0919_1F GCTTATCGATACCGTCGACCCTCGACAATTGGCGGAGGCAAG
TAAAGA 
VPA0919_1R CGACTTGAACTGCGATGCCTGCTGCTTGTTCCAGGCTTAC 
VPA0919_2F CAGGCATCGCAGTTCAAGTCGACTGTAGATACCCACGTACTTC 
VPA0919_2R CACTAGTGACGCGTACTCGAACTCATCAACCCAACGACG 
VPA 0477_1F GCTTATCGATACCGTCGACCCTCGACACGGCGGCAATTATCAT
CC 
VPA 0477_1R CGACTTGAACTGCGATGCCTGGCGTGGTGTTCTTCGTTCTT 
VPA 0477_2F CAGGCATCGCAGTTCAAGTCGGAACTCGAGCAACCAAGCC 
VPA 0477_2R CACTAGTGACGCGTACTCGAACAGTATCGAGCACCTGCTG 
VPA0920_pMM
B_F 
AGCTCGGTACCCGGGGATCCTCTAGTTGATTAAACAGTTTTTG
CTCGG 
VPA0920_pMM
B_R 
TCTCATCCGCCAAAACAGCCAAGCTTCAACGAGAAGCAGTGTC
TGTT 
VPA0919_pMM
B_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAGTGA
AACAGACACTGCTTC 
VPA0919_pMM
B_R 
TCTCATCCGCCAAAACAGCCAAGCTTTATGCTTTCATCTTGTAG
CCTA 
vpa0477_RBS_
pMMB_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATGAA
AAAGTTATTCCTGTTGG 
vpa0477_pMM
B_R 
TCCGCCAAAACAGCCAAGCTTTAACTTTCTTTGTAGTGCTCTA 
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VPA0920_pMM
B_His_R 
TCTCATCCGCCAAAACAGCCAAGCTTCAATGGTGGTGGTGATG
ATGTACGAGAAGCAGTGTCTGTT 
VPA0919_pMM
B_His_R 
TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGATG
ATGATGTGCTTTCATCTTGTAGCCTA 
VPA0920H286
A_1R 
AGCCGTTAAGATCTGTAAGAC 
VPA0920H286
A_2F 
GTCTTACAGATCTTAACGCTGAGCTTCGAACGCC 
VPA0919D51A
_1R 
AGCTAGGATGACAAGATCCG 
VPA0919D51A
_2F 
CGGATCTTGTCATCCTAGCTCGCCAGCTACCTG 
VPA0477_RT_
F 
GCGACATGGACAGCGGCAA 
VPA0477_RT_
R 
AATCGGTCAAGTCGCGTTGC 
secY_RT_F GGCATCATGCCGTATATTTCG 
secY_RT_R GGCAATCCAGCAACAATACC 
920SD_GST_F
BamHI 
AACGGATCCCTACCAGAACGCATAGATACG 
920SD_GST_R
XhoI 
AACCTCGAGGTGATCTTCTACATCCCAAC 
920L82A_1R CAGCGCAGCGAATACATGTC 
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920L82A_2F GACATGTATTCGCTGCGCTG 
920P125A_1R CACGCAGGTGGCGGTACTTAC 
920P125A_2F GTAAGTACCGCCACCTGCGTG 
920L95A_1R CCTGCAATTACTGAACCTCTAG 
920L95A_2F CTAGAGGTTCAGTAATTGCAGG 
 
 
 
 
Table2.3 Members of GO groups significantly overrepresented among up- and 
down-regulated genes in ΔvbrK strain (compared with WT) 
GO term 
 
No. of genes P value 
 
Peptidoglycan biosynthesis 10 
 
1.15E-05 
 
Protein export 5 0.014736 
 
β-Lactam resistance 
 
6 0.016001 
 
RNA degradation 5 0.020946 
 
Vancomycin resistance 3 0.023682 
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Pyruvate metabolism 
 
8 0.047559 
 
P < 0.05 was considered significantly different 
 
FIGURES 
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Figure 2-1. Identification of a histidine kinase that is essential for the resistance of V. 
parahaemolyticus to β-lactam antibiotics. 
(A) Mutants with deletion of predicted histidine kinases were streaked on LB agar plate 
containing 50 μg/mL carbenicillin. (B) ORF for the predicted histidine kinase that was 
deleted was shown. Deletion of vpa0920 abolished the ability of V. parahaemolyticus to 
resist ampicillin and penicillin. (C) Vpa0920 was designated as VbrK. Complementation 
of ΔvbrK with WT vbrK, but not mutant vbrK with point mutation H286A, restored 
carbenicillin resistance. Deletion of vbrR (vpa0919) abolished the ability of V. 
parahaemolyticus to resist carbenicillin. Complementation of ΔvbrR with WT vbrR, but 
not mutant vbrK with point mutation D51A, restored carbenicillin resistance. Expression 
of vbrR in trans in a plasmid cannot restore the carbenicillin resistance of ΔvbrK. 
 
 
 
 60 
 
Figure 2-2. VbrK is predicted to be a membrane protein. (A) The transmembrane region 
is predicted to be located at amino acids 9–16 and amino acids 240–260 
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(www.sbc.su.se/miklos/DAS/). Amino acids 25–240 are extracellular, whereas amino 
acids 261–484 are intracellular. (B) VbrK was expressed exclusively on the membrane, 
whereas VbrR is expressed as cytosolic protein. 
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Figure 2-3. RNA-seq analysis of genes that are regulated by VbrK. MA plots of relative 
transcript abundance between WT and ΔvbrK. The log2 of the ratio of 
abundances of each transcript between the two strains (M in y axis) is plotted 
against the average log2 of abundance of that transcript in both strains (A in x 
axis). 
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Figure 2-4. The role of VbrK/VbrR in the expression of β-lactamase. Indicated strains 
were cultured in LB. (A) RT-PCR analysis of blaA expression (Upper) with secY as 
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an internal control (Lower). (B) β-lactamase activity was measured by mixing V. 
parahaemolyticus whole-cell lysate with the β-lactamase substrate (nitrocefin). 
Once hydrolyzed, the degraded nitrocefin compound rapidly changes color from 
yellow to red. (C) OD490 was measured to reflect the relative amount of β-
lactamase produced by each individual bacterial strain. 
 
 
 
 
Figure 2-5. blaA is required for β-lactam resistance. (A) WT is resistant to carbenicillin. 
Deletion of blaA abolished carbenicillin resistance (B), whereas complementation of 
ΔblaA with a wild-type blaA restored carbenicillin resistance (C). 
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Figure 2-6. Regulation of blaA transcription and β-lactamase activity by β-lactam. (A) 
WT V. parahaemolyticus was cultured in M9. RT-PCR analysis of the blaA transcription 
in the presence or absence of carbenicillin. (B) The activity of β-lactamase activity in WT 
V. parahaemolyticus treated with increasing dose of carbenicillin. (C) β-Lactamase 
activity was measured at different time points after carbenicillin was added. (D) β-
Lactamase activity in WT V. parahaemolyticus 
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treated with β-lactam and other lactams including e-caprolactam,δ-valerolactam, and 2 
azacyclononanone. 
 
 
 
 
 
FIgure 2-7. Regulation of β-lactamase activity by VbrK/VbrR and carbenicillin. (A) β-
Lactamase as indicated by the color change from yellow to red in WT V. 
parahaemolyticus treated with different doses of carbenicillin. (B) β-Lactamase 
activity in WT V. parahaemolyticus treated with ampicillin and penicillin. (C) β-
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Lactamase was activated by carbenicillin in a time-dependent manner. (D) β-
Lactamase was activated only by β-lactam, and not by other lactams. (E) The 
structures of β-lactam, e-caprolactam, δ-valerolactam, and 2-azacyclononanone 
are shown. (F) Growth curve of WT and ΔvbrK in LB in the presence or absence 
of carbenicillin. 
 
 
 
 
 
 
 
 
Figure 2-8. The role of β-lactam in the phosphorylation of VbrK and VbrR when V. 
parahaemolyticus was cultured in LB. (A) Phosphorylation analysis of VbrK or 
VbrKH286A in the indicated strains in the presence or absence of carbenicillin. 
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(B) Phosphorylation analysis of VbrR or VbrRD51A in the indicated strains in the 
presence or absence of carbenicillin. 
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Figure 2-9. Identification of VbrK amino acid residues essential for specific recognition 
of different lactams. Indicated strains were cultured in M9. (A) VbrK phosphorylation 
was measured at different time points after carbenicillin was added to the culture. 
Phosphorylation of VbrK (B), VbrKL82A (C), VbrKL95A (D), and VbrKP125A (E) in 
V. parahaemolyticus in the presence of carbenicillin (lane 2), e-caprolactam (lane 
3), δ-valerolactam (lane 4), and 2-azacyclononanone(lane 5) or in the absence of 
any lactams (lane 1). (F) Indicated strains were untreated (black bar) or treated 
with carbenicillin (green bar), e-caprolactam (gray bar), δ-valerolactam (yellow 
bar), and 2-azacyclononanone (blue bar), and OD490 was measured to indicate β-
lactamase activity. 
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Figure 2-10. The extracellular portion of VbrK (amino acids 25–240) was predicted 
by Phyre2 (www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) to have a pocket 
domain. The amino acids that form the pocket are highlighted in red. These amino 
acids highlighted in red include Y71, D75, I76, Q78, L79, L82, L95, I96, T97, P99, 
L100, and P125. 
 71 
 
 
Figure 2-11. β-Lactamase activity of various strains (shown on right) of V. 
parahaemolyticus in response to the treatment of β-lactam (carbenicillin) and other 
lactams. The color change from yellow to red indicates the ability of whole-cell lysate to 
hydrolyze nitrocefin. 
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Figure 2-12. In vitro analysis of VbrK phosphorylation and interaction between VbrK and 
β-lactam. (A) Membrane extracts from E. coli expressing 6xHis-tagged VbrK (lanes 4 
and 5) or VbrKH286A (lanes 2 and 3) were treated with carbenicillin (lanes 3 and 5) or 
left without treatment of carbenicillin (lanes 2 and 4). No addition of ATP was used as a 
negative control (lane 1). Following treatment, each sample was resolved in the Phos-
tag gel (Upper) or regular gel (Lower) and blotted with anti-His antibody. (B) In vitro 
phosphorylation assay for VbrK treated with carbenicillin (lane 1), e-caprolactam (lane 
2), δ-valerolactam (lane 3), and 2-azacyclononanone (lane 4). (C and D) Analysis of 
binding between the VbrK sensor domain (VbrKSD) and penicillin. Microtiter plate was 
precoated with GST-VbrKSD, GST-VbrKSD_L82A, or GST, or without protein coating. 
Penicillin (50 ng or 500 ng) was added to the precoated plate. Following sufficient 
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washing, anti-penicillin antibody and HRP secondary antibody were added. Blue color 
formation was observed (D) and OD370 was measured (C) to reflect the relative 
amount of penicillin that binds to the coated proteins. (E) Pulldown assay was 
performed 
by addition of equal amount of GST-VbrKSD (lane 2) or GST-VbrKSD_L82A (lane 1) 
into the protein G Sepharose immobilized with penicillin and anti-penicillin antibody. (E) 
After sufficient washing, protein elution was probed with anti-GST antibody. (F) 
Schematic model for VbrK/VbrR-mediated β-lactamase expression. 
 
 
Figure 2-13. Purification of VbrK sensor domain. E. coli strains containing the vectors 
that express GST-VbrKSD, GST-VbrKSD_L82A, or GST alone were subcultured in LB 
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for 1h, followed by addition of 1 mM IPTG for protein expression. The protein was 
purified  and resolved in SDS/PAGE and stained by Coomassie blue. An equal amount 
of each protein was used to coat the microtiter plate. 
 
 
 
Figure 2-14. Alignment of the sensor domain of VbrK (amino acids 1–240) from different 
Vibrio species. Amino acids in the red boxes are these that govern the specificity of 
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sensing β-lactams. Amino acids with an asterisk (*) at the bottom are identical across 
different Vibrio species. 
 
Chapter 3. Histidine Kinase Activated by Multiple Signals and Mediates 
Resistance to Antimicrobial Peptide and Vancomycin 
3.1 Introduction 
Antimicrobial peptides (AMPs) are unique in that they are amphipathic so that they can 
partition into phospholipid bilayer and destruct bacterial cell membrane. AMPs exist in 
broad domain of life including bacteria, fungi, and human. For example, cathelicidin LL-
37 is widely expressed by many different types of cells including epithelium, T cells and 
B cell, and plays important role in both innate and adaptive immunity (116). AMPs of 
bacterial origin (Bacillus polymyxa) such as polymyxin B and polymyxin E have been 
obtained for clinical use, and is recognized as the last resort antibiotics for the treatment 
of gram negative pathogen infection, especially for the multidrug resistant strains (117). 
Pathogens have developed various mechanisms to fight against AMP, one of the 
principal mechanisms is through modification of lipopolysaccharides (LPS). As LPS is 
anionic due to phosphate group attached to lipid A, AMPs can replace cationic ions that 
stabilize the LPS, and insert into outer membrane. The modified LPS carries reduced 
negative charges, thus become more resistant to the disturbance of AMP brings up.  
Gram negative pathogens have developed different schemes of LPS modification, many 
of which are regulated by two component systems(TCSs). For example, the famous 
PhoP/PhoQ system in Salmonella can be activated by acidic pH, specific AMPs or 
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depletion of Mg2+ or Ca2+, and leads to subsequent expression of pagP and pagL that 
acylate or deacylate lipid A (118). In P. aeruginosa,PhoP/PhoQ system can upregulate 
expression of  Ara4N synthesis operon and stimulate Arap4N addition to lipid A. Despite 
the evidence that TCS plays an important role in the induction of LPS modification and 
that Mg2+ and C18G (a human platelet factor), there is no direct evidence that correlates 
the environmental stimulation to HK phosphorylation and the resultant development of 
AMP resistance.  
Vibrio parahaemolyticus is the leading cause of seafood-borne diarrheal disease 
worldwide. The emergence of multi-drug resistant V.parahaemolyticus is making the 
treatment more and more challenging. At the time we initiated these studies, there was 
minimal knowledge of the mechanisms underlying V. parahaemolyticus resistance to 
AMPs. Although one proteomic study suggested that V.parahaemolyticus might obtain 
their resistance against AMPs through upregulation of multidrug efflux transporter or 
effective repair of damaged membranes, no gene or mechanism has been confirmed 
(128). Here, we reported an unidentified mechanism in Vibrio parahaemolyticus by 
showing direct evidence that low Mg2+ concentration or AMP stimulate the 
phosphorylation of HK, and leads to expression of enzyme that modifies LPS.  
 
3.2 Material and methods 
3.2.1 Construction of plasmids 
All deletion mutants were generated by allelic exchange using the suicide vector pDM4 
as described in chapter 2. Complementation was conducted by cloning the respective 
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genes in the low-copy (approximately seven copies per cell) vector pMMB207 as 
described in chapter 2.  
 
Plasmid pDM4-1276. The up- and downstream regions flanking vpa1276 (pvrR) were 
amplified using primer pairs VPA1276_1F/ VPA1276_1R and 
VPA1276_2F/VPA1276_2R, respectively. The resulting product was inserted into XhoI-
digested pDM4, resulting in plasmid pDM4-1276 (Table 3.1). This plasmid was used to 
generate pvrR deletion mutant. 
 
Plasmid pDM4-1280. The up- and downstream regions flanking vpa1280 (eptA) were 
amplified using primer pairs VPA1280_1F/ VPA1280_1R and 
VPA1280_2F/VPA1280_2R, respectively. The resulting product was inserted into XhoI-
digested pDM4, resulting in plasmid pDM4-1280 (Table 3.1). This plasmid was used to 
generate eptA deletion mutant. 
Plasmid pDM4- 1279/1280. The up- and downstream regions flanking vpa1279-
vpa1280 (dgkA-eptA) were amplified using primer pairs VPA1279_1F/ VPA1279_1R 
and VPA1280_2F/VPA1280_2R, respectively. The resulting product was inserted into 
XhoI-digested pDM4, resulting in plasmid pDM4-1279/1280 (Table 3.1). This plasmid 
was used to generate dgkA-eptA double-deletion mutant.  
Plasmid pDM4-1277H221A. The up- and downstream regions flanking vpa1277 (pvrK) 
were amplified using primer pairs VPA1277_1F/ 1277H221A_PDM4_R and 
1277H221A_PDM4_F /VPA1277_2R, respectively. The resulting product was inserted 
into XhoI-digested pDM4, resulting in plasmid pDM4-1277H221A (Table 3.1). This 
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plasmid was used to generate pvrKH221A  single amino acid mutant. The resulting mutant 
was confirmed by primer set 1277H221A_CPM_F/ 1277H221A_CPM_R.  
Plasmid pDM4-1276D58A. The up- and downstream regions flanking vpa1276 (pvrR) 
were amplified using primer pairs VPA1276_1F/ 1276D58A_PDM4_R and 
1276D58A_PDM4_F /VPA1276_2R, respectively. The resulting product was inserted 
into XhoI-digested pDM4, resulting in plasmid pDM4-1276D58A (Table 3.1). This 
plasmid was used to generate pvrRD58A  single amino acid mutant. The resulting mutant 
was confirmed by primer set 1276D58A_CPM_F/ 1276D58A_CPM_R.  
 
Plasmid pMMB207-1276. The pvrR gene was amplified using primers 
VPA1276_PMMB_RBS_F and VPA1276_PMMB_HIS_R. A 6xHis tag was added at the 
C terminus. The PCR product was inserted into BamHI, XbaI double-digested 
pMMB207, resulting in plasmid pMMB207-1276 (Table 3.1). This plasmid was used to 
complement ΔpvrR and protein expression for phosphorylation assay. 
Plasmid pMMB207-1277. The pvrR gene was amplified using primers 
VPA1277_PMMB_RBS_F and VPA1277_PMMB_HIS_R. A 6xHis tag was added at the 
C terminus. The PCR product was inserted into BamHI, XbaI double-digested 
pMMB207, resulting in plasmid pMMB207-1276 (Table 3.1). This plasmid was used to 
complement ΔpvrK and protein expression for phosphorylation assay. 
Plasmid pMMB207-1280. The gene for eptA was PCR amplified from V. 
parahaemolyticus using primers VPA1280_RBS_pMMB_F and 
VPA1280_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI double-
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digested pMMB207, resulting in plasmid pMMB207- 1280 (Table 3.1). This plasmid was 
used to complement ΔdgkA-eptA and ΔpvrK. 
Plasmid pMMB207-1279. The gene for dgkA was PCR amplified from V. 
parahaemolyticus using primers VPA1279_RBS_pMMB_F and 
VPA1279_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI double-
digested pMMB207, resulting in plasmid pMMB207- 1279 (Table 3.1). This plasmid was 
used to complement ΔpvrK. 
Plasmid pMMB207-1279/1280. The gene for eptA was PCR amplified from V. 
parahaemolyticus using primers VPA1279_RBS_pMMB_F and 
VPA1280_PMMB_HIS_R. The PCR product was inserted into BamHI, XbaI double-
digested pMMB207, resulting in plasmid pMMB207- 1280 (Table 3.1). This plasmid was 
used to complement ΔeptA and ΔpvrK. 
 
Plasmid pMMB207-1277-H221A. Point mutation H221A was introduced in the coding 
sequence of pvrK by PCR using primer pairs VPA1277_pMMB_F/VPA1277H221A_1R 
and VPA1277- 
H221A_2F/VPA1277 pMMB_R, respectively. A 6xHis tag was added at the C terminus. 
The PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting 
in plasmid 
pMMB207-1277-H221A (Table 3.1). This plasmid was used to express PvrKH221A 
protein. 
Plasmid pMMB207-1276-D58A. Point mutation D58A was introduced in coding 
sequence of pvrR by PCR amplification from V. parahaemolyticus using primer pairs 
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VPA1276_PMMB_RBS_F /VPA1276- D58A_1R and VPA1276D58A_2F/ 
VPA1276_PMMB_HIS_R, respectively. A 6xHis tag was added at the C terminus. The 
PCR product was inserted into BamHI, XbaI double-digested pMMB207, resulting in 
plasmid pMMB207-1276-D58A. This plasmid was used to express PvrRD58A protein. 
Plasmid pGEX-1277SD. The coding sequence for hypothetical sensor domain (amino 
acids 28–138) of PvrK was PCR amplified from V. parahaemolyticus using primers 
1277_SENDOMIN_BAMHI_F and 1277_SENDOMIN_ECORI_R. The resulting PCR 
product was digested with BamHI or XhoI, accordingly, and inserted into the equivalent 
site of plasmid pGEX, resulting in plasmid pGEX-1277SD (Table 3.1). This plasmid was 
used to express the GST-tagged sensor domain of PvrK. 
 
3.2.2. Construction of deletion/ single amino acid mutants and complementation 
strain 
The construction of deletion and single amino acid mutants are constructed using 
pDM4- based plasmids (Table 3.1) as described in Chapter2.  
3.2.3 RNA-seq analysis 
Bacteria were grown in LB supplemented with 50 μg/mL carbenicillin for 3 h. Total RNA 
was isolated by RNEasy kit (Qiagen) according to the manufacturer’s instruction. RNA 
samples were treated with DNase, followed by the removal of rRNA using the RiboZero 
kit for Gram-negative bacteria (Epicentre). Bacterial mRNA was fragmented to yield 
fragments in the range of 60–200 nt. The fragmented RNA and random primers were 
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used for the synthesis of first-strand cDNA. Second strand cDNA was synthesized 
subsequently. Libraries for Illumina sequencing were generated by adding Illumina-
specific adaptors to cDNA. Reads from Illumina sequencing were aligned to 
chromosomes I and II of V. parahaemolyticus. The total number of reads that can be 
aligned to the genome was calculated. Subsequently, total reads per gene were 
normalized by RPKM [(reads/kb of gene)/(million reads aligning to genome)]. Kabos 3.0 
(119)is used to analyze KEGG pathways and involved genes that have been affected 
(more than 3 times) in ΔpvrK.  
 
3.2.4 RNA extraction and RT-PCR 
Bacteria were grown in LB supplemented with or without 50 μg/mL carbenicillin for 3 h. 
Total RNA was isolated by RNEasy kit (Qiagen) according to the manufacturer’s 
instruction. RNA samples were treated with DNase at 37°C to remove any DNA 
contamination. First strand of cDNA was synthesized by SuperScript™ III First-Strand 
Synthesis System (Invitrogen), and following PCR was performed using gene-specific 
primers (Table 3.2). and secY was used as an internal control. 
 
 
3.2.5 Phosphorylation assay 
Phostag-SDS-PAGE were used to determine the phosphorylation status of a protein. 
Bacterial strains harboring PvrK or PvrR vectors were grown in LB or LB with different 
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concentrations of Mg2+ or Marine broth(Difco) with treatment of carbenicillin (50 μg/mL) 
and chloramphenicol (50 μg/mL). Following 3 h of treatment, whole-cell lysate was 
obtaining by sonication and resolved in 12% (wt/vol) SDS gels (29:1) containing 50 μM 
Phos-tagWAKO acrylamide and 100 μM MnCl2. After 30 minutes incubation of the 
phos-tag acrylamide gel in wash buffer (25mMTris, 190mM glycin, 10mM EDTA, 20% 
methanol), proteins in the Phos-tag gels were transferred onto a nitrocellulose 
membrane, and protein mobility shift was determined by Western blot using HRP-
conjugated, anti-His antibody.  
 
3.3 Results 
3.3.1 Identification of a histidine kinase that is essential for for V. 
parahaemolyticus resistance to antimicrobial peptide 
As described in previous chapters, 32 TCSs of V. parahaemolyticus were identified 
through gene annotation and 31 mutants were successfully created, each containing a 
deletion of an individual ORF encoding a putative histidine kinase. Notably, it was found 
that one of the mutants, harboring a deletion of vpa1277, exhibited increased sensitivity 
toward polymyxinB, LL-37, polymyxinE and vancomycin (Fig.3-1). Complementation of 
the Δvpa1277 mutant with a wild-type vpa1277 in trans restored resistance to polymyxin 
B (Fig. 3-1C), indicating that vpa1277 is important for polymyxin B resistance. These 
results indicate that the predicted histidine sensor kinase vpa1277 (now designated as 
PvrK for Vibrio antimicrobial peptide resistance sensor kinase) is essential for V. 
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parahaemolyticus AMP resistance. PvrK is composed of 428 amino acids, of which aa 
1-158 is of unknown functions. The region encompassing amino acids 158-205 is 
predicted to be a HAMP domain, which is a cytoplasmic helical linker domain that is 
common in histidine kinases or methyl-accepting proteins. The region from amino acids 
214 to 275 is the ATPase histidine kinase A (HisKA) domain which is a phosphor-
acceptor, and the region from amino acids 321 to 427 is predicted to be a ATPase. PvrK 
is predicted to be a membrane protein (TMHMM prediction) with two potential 
transmembrane regions located at amino acids 8–21 and amino acids 140–161, 
respectively (Fig. 3-2). Amino acids 28–138 are predicted to be located extracellularly, 
whereas amino acids 162–428 are predicted to be located intracellularly. 
 
3.3.2 Identification of genes that are regulated by PvrK 
We carried out RNA sequencing (RNA-seq) experiments to identify the PvrK regulon, 
with the ultimate goal of elucidating the mechanisms by which this histidine kinase 
regulates AMP and vancomycin resistance. In these experiments, we compared the 
transcriptomes of wild-type and ΔpvrK V. parahaemolyticus grown in LB. For the PvrK 
regulon, transcriptomes of wild-type and ΔpvrK V. parahaemolyticus grown in LB were 
compared. It was found that 120 (2.5%) and 44 (0.9%) of the 4,868 annotated V. 
parahaemolyticus ORFs were significantly up- and down-regulated (more than twofold), 
respectively, in the ΔpvrK strain compared with WT. KEGG pathways that were 
significantly reduced (more than twofold) in the ΔpvrK mutant compared with the WT 
include those involving LPS synthesis, cationic antimicrobial peptide(CAMP) resistance, 
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and bacterial secretion systems and ABC transporters (Fig. 3-3). Gene in the CAMP 
resistance category of PvrKR regulon include vpa1280 encoding lipid A ethanolamine 
phosphotransferase (eptA), and the gene in the LPS synthesis pathway include vp2509 
encoding lipid A biosynthesis lauroyl acyltransferase. Transcripts of Vp2509 decreased 
6.7 times in ΔpvrK mutant while transcripts of eptA decreased 4.4 times in ΔpvrK 
mutant. The gene vpa1279 was also brought into attention since it is very adjacent to 
vpa1280 (22bp upstream) and its transcription level decreased by 3.8 times in ΔpvrK 
mutant. It is speculated that vpa1279 might form an operon with vpa1280. Vpa 1279 
encodes a diacylglycerol kinase (dagK) which  catalyzes the conversion 
of diacylglycerol (DAG) to phosphatidic acid (PA), utilizing ATP as a source of the 
phosphate. 
 
Except for the three genes mentioned above, the transcription level of genes predicted 
to be involved in ABC transporter which include vp1999, vpa0318 and vpa0810 also 
decreased more than three times in ΔpvrK. vpa0242 and vpa0243 also caught up the 
attention in that transcription level of vpa0243 dropped more than 70 times while 
transcription level of vpa0242 dropped 29.5 times in ΔpvrK in comparison to WT. 
vpa0243 is predicted to encode a VirK protein which is periplasmic and is required for 
efficient secretion of toxins in enteroaggregative Escherichia coli(EAEC) (120).  I 
performed RT-PCR analyses to verify that eptA and other genes are regulated by PvrK. 
The transcription profile of all the tested genes are in accordance with RNA-seq results. 
Notably, expression of eptA was dependent on PvrK; we observed eptA expression in 
the WT strain, but not in the ΔpvrK strain (Fig. 3-4, lane 4). Transcription level of dagK 
in ΔpvrK also decreased but not as obvious as of that eptA (Fig. 3-4, lane 5).  
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3.3.3 Pvrk and PvrR Can Be Phosphorylated on Its Conserved Histidine Residue 
In Vivo. 
Histidine kinases usually contain a conserved histidine residue that can be 
phosphorylated, and such phosphorylation is essential for its signal transducing 
function. We determined PvrK phosphorylation using phos-tag SDS-PAGE. The 
complex of phos-tag and Mn2+ ion can preferentially bind to phosphate group in a 
protein, so that the migration speed of phosphorylated protein decreases and they are 
separated from non-phosphorylated proteins (98).  In this experiment, the bacteria is 
grown in LB broth and whole-cell lysate was obtained for SDS/PAGE and Western blot. 
A shifted band (PvrK-P) of PvrK_6xHis was detected when proteins were separated in 
Phos-tag gel (Fig. 3-5), indicating that PvrK was phosphorylated. When the conserved 
histidine residue at the 221th amino acid of PvrK was substituted with alanine (H221A), 
PvrK phosphorylation was abolished (Fig. 3-5), indicating that PvrK phosphorylation is 
dependent on its conserved histidine residue.  
 
3.3.4 PvrK Genetically but Not Functionally Forms a TCS with Its Response 
Regulator PvrR. 
Deletion of pvrR, the putative response regulator located immediately upstream to pvrK 
on the chromosome, abolished polymyxinB, polymyxinE and vancomycin resistance 
(Fig. 3-1C &E). Complementation of ΔpvrR with a WT pvrR gene in trans restored 
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polymyxinB, polymyxinE and vancomycin resistance, indicating that PvrR is essential 
for AMP resistance. More importantly, when conserved aspartate was mutated to 
alanine, the bacteria also lost its resistance to above mentioned AMPs. Together, these 
observations strongly suggest that PvrK and PvrR form a TCS that controls V. 
parahaemolyticus resistance to AMP and vancomycin. To determine if PvrR can be 
phosphorylated, we expressed PvrR_6xHis in ΔpvrR, and phosphorylation was 
assessed using the Phos-tag assay. A shifted band (PvrR-P) of PvrR_6xHis was 
observed, and when the conserved aspartate residue at 58th amino acid of PvrR was 
substituted with alanine (D58A), PvrR phosphorylation was abolished (Fig. 3-5), 
indicating that PvrR phosphorylation is dependent on its conserved aspartate residue. 
The phosphorylation assay also indirectly confirmed the hypothesis based its amino 
acid sequence and predicted conformation that PvrK and PvrR are HK and RR 
functionally. Surprisingly, complementation of WT PvrR into ΔpvrR or pvrRD58A barely 
restored the pvrR mutants’ phenotype (Fig 3-6A). For phosphorylation assay, PvrR can 
still be phosphorylated when PvrK is absent or mutated (Fig. 3-6B).  
3.3.5 EptA is essential but does not fully account for AMP resistance  
Because the transcription level from both vpa1279 and vpa1280 decreased in RNA-seq, 
Δvpa1279-1280 and its corresponding complementation strain were created and tested 
for polymyximB resistance. Deletion of both vpa1279-1280 genes abolished AMP 
resistance while complementation of Δvpa1279-1280 with WT Vpa1279-80 restored the 
resistance (Fig.3-7B).  
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Because PvrK is critical for the transcription of eptA in RT-PCR assay (Fig. 3-4) but not 
dagK, and eptA is predicted to encode a lipid A ethanolamine phosphotransferase (PEA 
transferase), which adds positively charged phosphoethanolamine (PEA) to the core of 
lipid A head groups and results in a less negatively charged LPS that is more resistant 
to AMP disturbance.  It is hypothesized that eptA is responsible for AMP resistance in V. 
parahaemolyticus. To confirm this hypothesis, eptA knockout mutant was constructed 
and streaked onto plates with polymyxinB. Because vpa1279 (dagK) is immediately 
(22bp) upstream of eptA(vpa1280) and because its transcription dropped heavily in 
RNA-seq results, constructs of ΔdagK is also generated. Both knockouts exhibited 
increased sensitivity toward polymyxinB (Fig.3-7A). Complementation of either eptA or 
dagK to pvrK mutant did not fully restore resistance to polymyxinB (data not shown), 
implying that both genes contribute to polymyxinB resistance for the bacteria. 
Complementation of both dagK and eptA to pvrK mutants fully restored polymyxinB 
resistance to WT level (Fig.3-7A). Interestingly, complementation of EptA or DagK to 
their respective deletion mutant cannot fully restore the polymyxinB resistance to wild 
type level. One possible explanation is that the vpa1279-vpa1280 forms an operon and 
deletion of a single gene destruct the promoter or terminator motifs, however, this 
explanation contradicts the RT-PCR result where transcription level of eptA and dagK 
was not eaxctly the same. Another explanation is that the deletion of dagK is not in 
triplet frame and affected expression of eptA.  
 
3.3.6 High Mg2+ Concentration Abolished Phosphorylation of Pvrk And 
Transcription Of eptA 
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As Mg2+ plays important parts in stabilizing LPS, and previous study has reported that 
the PhoPQ system mediated Mg2+-dependent modifications in 
lipopolysaccharides(121),we hypothesized that concentrations of Mg2+ affect PvrK 
phosphorylation. The Bacteria is grown in LB, LB broth supplemented with 2mM and 
10mM of Mg2+, and harvested and sonicated for Phos-tag SDS-PAGE and western blot. 
A shifted band (PvrK-P) of PvrK_6xHis was detected when the protein is extracted from 
V. parahaemolyticus growing in plain LB. The shifted band is thinner when PvrK was 
extracted from V. parahaemolyticus growing with 2mM Mg2+ supplement. The band of 
PvrK-P further faded away when V. parahaemolyticus grows with 10mM Mg2+ (Fig3-8 
A). This result indicated that phosphorylation of PvrK is affected by concentrations of 
Mg2+ on a dose dependent manner. To further confirm the role of Mg2+, transcriptional 
level of eptA was tested under different growth conditions. In LB with high 
concentrations of Mg2+, the transcriptional level of eptA plummeted in comparison to Lb 
broth. Interestingly, the transcription of vpa0243, the gene that is also regulated by pvrK 
and is responsible for vancomycin resistance, does not change in respond to Mg2+ level 
in LB media (Fig3-8 B).  
 
3.3.7 AMP Restored Pvrk Phosphorylation and eptA Transcription with High 
Concentrations of Mg2+ 
Since activation of PvrK and expression of eptA is responsible for AMP resistance, we 
are wondering whether AMP can reverse the phosphorylation status of PvrK with high 
concentrations of Mg2+ in the environment. We grew bacteria in LB, LB with 10mM 
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Mg2+, and LB supplemented with 10mM Mg2+ and sub-lethal concentrations of 
polymyxin B (5ug/ml). As the shifted band (PvrK-P) of PvrK_6xHis faded away in PvrK 
from 10mM Mg2+, the addition of AMP restored intensity of PvrK-P, indicating that AMP 
can reverse the negative effect of high Mg2+ on phosphorylation status of PvrK (Fig.3-
9A). Similarly, as the result of RT-PCR showed, transcription level of eptA in high 
concentration(10mM) of Mg2+ is as low as that of PvrKH221A mutant, while addition of 
polymyxinB restored the eptA transcription level (Fig.3-9B).  
 
3.4 Discussion 
In this study, we show that histidine kinase PvrK is activated by AMP while inhibited by 
high comcentration of Mg2+ in the environment. The phosphorylation of PvrK triggers 
transcription of eptA, a lipid A ethanolamine phosphotransferase and endows AMP 
resistance Gram-negative bacterium V. parahaemolyticus. This conclusion was 
supported by the results that (i) deletion of PvrK or its response regulator PvrR greatly 
reduced the transcription of eptA and abolished the AMP resistance; (ii) deletion of eptA 
abolished AMP resistance (iii) PvrK phosphorylation is promoted by addition of AMP to 
LB media, or a low Mg2+ in the environment. Based on the results, a model was 
proposed where membrane - associated histidine kinase PvrK sense the low Mg2+ 
concentration or the presence of AMP in the environment, leading to the PvrK 
phosphorylation, phosphoryl transfer to PvrR, and, ultimately, the expression of PEA 
transferase and less negatively charged LPS (Fig.3-10).  
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AMP is the antibiotic that specifically target Gram negative bacteria as it binds to and 
destructs LPS, a structure that is unique to gram negative bacteria. Except for efflux 
pumps and formation of capsule, one of the most widespread resistance mechanism is 
the covalent modification of LPS. The modifications include addition of fatty acid, 4-
amino-4-deoxy-L-arabinose (Ara4N) or phosphoethanolamine addition to the core and 
lipid A, and acetylation of the O-antigen (122). One of the famous examples is that in S. 
typhimurium, the TCSs of PmrA-PmrB and PhoP-PhoQ regulates AMP resistance by 
regulating multiple lipid A modification genes, including genes involved in addition of 
ethanolamine and aminoarabinose to the 4′ phosphate of lipid A (123). Moreover, it was 
also reported that PhoPQ mediated regulation can produce a more robust outer 
membrane with lower permeability, leading to increased resistance to multiple drugs 
(124). Bader et.al fused a PhoPQ – regulated gene to PhoN reporter gene and showed 
that AMP can activate reporter gene expression at intermediate Mg2+ concentrations; 
moreover, they showed that the presence of AMP increased the kinase activity of PhoQ, 
and speculated AMP can bind to periplasmic region of the PhoQ by Fe2+ mediated 
cleavage assay and fluorescence assay (125). However, the gene regulated by PhoPQ 
in their study was not shown to be responsible for any phenotype of S. typhimurium, 
including the AMP resistance or Mg2+ concentration sensation. In contrast, our study 
directly built up the causality between Mg2+ concentration/ AMP presentation to PvrK 
phosphorylation and eptA expression. Furthermore, this mechanismof AMP resistance 
is the first to be discovered in the Genus of Vibrio, this genus includes notorious 
pathogens like Vibrio cholera and Vibrio parahaemolyticus.    
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Another interesting finding of this study relies in the fact that although PvrR genetically 
forms a cognate TCS with PvrK, where the knockout mutant of pvrK or pvrR lost AMP 
resistance, PvrR can still be phosphorylated without a functional PvrK. There are 
basically two explanations for this scenario. The first possibility is that there existence of 
cross talks between two different TCSs which is not uncommon in many cases (83). 
When the cognate HK is un-functional, the RR can be phosphorylated by an alternative, 
non-cognitive HK. A second possibility is that RR can be phosphorylated by alternative 
phosphor-donors, such as acetyl phosphate. On the other hand, since complementation 
of PvrR does not compensate ΔpvrK while the knockout of pvrR abolished AMP 
resistance, it can be concluded that pvrR is essential but not sufficient for AMP 
resistance, there must exist another regulatory protein that can be activated by PvrK 
that is also responsible for AMP resistance.  
 
In this study, we found that either low concentrations of Mg2+ or the presence of sub-
lethal concentration of AMP resulted in LPS modification and thus AMP resistance of V. 
parahaemolyticus. As V. parahaemolyticus is naturally found in the sea water, the high 
salinity, especially the high concentration of Mg2+ (50mM) (126) of sea water, stabilize 
the LPS of the outer membrane, so that LPS does not have to be modified or masked 
with neutral or cationic groups; in this regard, PvrK remains inactivate and transcription 
of eptA remains at minimal level. When the pathogen invades into human or other 
animals, where the concentration of Mg2+ is around 1.08mM (127), the low Mg2+ 
concentration activate the PvrK and transcription of eptA. Moreover, as certain 
members of AMP such as LL-37 is naturally present in human, and is part of the innate 
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immunity, the presence of AMP further activate PvrK phosphorylation and the 
development of AMP resistance in V. parahaemolyticus. Thus, the TCS of PvrK-PvrR 
system can be also viewed as an important virulence factor that aids the survival, 
persistence and invasion of V. parahaemolyticus upon infection.  
 
 
 
 
Tables 
 
Table 3.1 Strains and plasmids 
Strains Relevant 
genotype/description 
Source 
Vibrio parahaemolyticus 
RIMD 2210633 
Clinical isolate (10) 
ΔpvrK RIMD 2210633 
Δvpa1277 
This work 
ΔpvrR RIMD 2210633 
Δvpa1276 
This work 
ΔeptA RIMD 2210633 
Δvpa1280 
This work 
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ΔdgkA-eptA RIMD 
2210633Δvpa1279-1280 
This work 
ΔpvrK:ppvrK ΔpvrK complemented 
with pvrK gene located in 
pMMB207 
This work 
ΔpvrR:ppvrR ΔpvrR complemented 
with pvrR gene located in 
pMMB207 
This work 
ΔeptA:peptA ΔeptA complemented 
with eptA gene located in 
pMMB207 
This work 
ΔpvrK:peptA ΔpvrK containing eptA 
gene located in 
pMMB207 
This work 
ΔpvrK:pdgkA ΔpvrK containing dgkA 
gene located in 
pMMB207 
This work 
ΔpvrK:pdgkA-eptA ΔpvrK containing dgkA-
eptA gene located in 
pMMB207 
This work 
ΔpvrK:ppvrR ΔpvrK containing pvrR 
gene located in 
pMMB207 
This work 
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ΔpvrK:ppvrKH221A ΔpvrK complemented 
with mutated pvrK 
gene(H221A) located in 
pMMB207 
This work 
ΔpvrR:ppvrRD58A ΔpvrR complemented 
with mutated pvrR 
gene(D58A) located in 
pMMB207 
This work 
Escherichia coli 
SM10λpir 
KmR, thi-1, thr, leu, tonA, 
lacY, supE, recA::RP4-2-
Tc::Mu, λpir 
This work 
Escherichia coliDH5αλpir supE44, 
ΔlacU169(ΦlacZΔM15), 
recA1, endA1, hsdR17, 
thi-1, gyrA96, relA1, λpir 
This work 
 
Plasmids   
pDM4-1276 Plasmid for deletion of 
vpa1276 
This work 
pDM4-1277 Plasmid for deletion of 
vpa1277 
This work 
pDM4-1280 Plasmid for deletion of 
vpa1280 
This work 
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pMMB207-1276 RBS and vpa1276 
sequences cloned into 
pMMB207 
This work 
pMMB207-1277 RBS and vpa1277 
sequence cloned into 
pMMB207 
This work 
pMMB207-1280 RBS and vpa1280 
sequences cloned into 
pMMB207 
This work 
pMMB207-1276His RBS and vpa1276 
sequences with 6His 
amino acid sequences 
cloned into pMMB207  
This work 
pMMB207-1277His Vpa1277 sequences and 
6His amino acid 
sequences cloned into 
pMMB207 
This work 
pMMB207-1277-H221A vpa01277 sequences 
with a point mutation in 
histidine 221 and 
sequences for 6His 
amino acid cloned into 
pMMB207 
This work 
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pMMB207-1276-D58A Vpa1276 sequences with 
a point mutation in 
aspartic acid 58 and 
sequences for 6His 
amino acid cloned into 
pMMB207 
This work 
pGEX-1277SD Sequences of vpa1277 
sensor domain cloned 
into pGEX 
This work 
pMMB-1277-T82A Sequences of vpa1277 
with a point mutation in 
threonine 82 cloned into 
pMMB207 
This work 
pMMB-1277-L85A Sequences of vpa1277 
with a point mutation in 
leucine 85 cloned into 
pMMB207 
This work 
pMMB-1277-K90A Sequences of vpa1277 
with a point mutation in 
lysine 90 cloned into 
pMMB207 
This work 
pMMB-1277-E91A Sequences of vpa1277 
with a point mutation in 
This work 
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glutamic acid 91 cloned 
into pMMB207 
pMMB-1277-V92A Sequences of vpa1277 
with a point mutation in 
valine 92 cloned into 
pMMB207 
This work 
pMMB-1277-F93A Sequences of vpa1277 
with a point mutation in 
phenylalanine 93 cloned 
into pMMB207 
This work 
pMMB-1277-F113A Sequences of vpa1277 
with a point mutation in 
phenylalanine 113 cloned 
into pMMB207 
This work 
 
 
 
 
Table 3.2 Primers used in this study 
PRIMER NAME SEQUENCE (5’-3’) 
VPA1277_1F GCTTATCGATACCGTCGACCCTCGAAGATTTGATGCTGCCG
GGC 
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VPA1277_1R CGACTTGAACTGCGATGCCTGTTATGCGTTCCATGCATCCG 
VPA1277_2F CAGGCATCGCAGTTCAAGTCGCGGGCGAACAACGATAAAAG 
VPA1277_2R CACTAGTGACGCGTACTCGACGAGAGCTTGTGTTTTGGTG 
VPA1276_1F GCTTATCGATACCGTCGACCCTCGAAAGACGTTCCCTGACC
ACG 
VPA1276_1R CGACTTGAACTGCGATGCCTGGTAAGTGATGTGTGCTGTAT
TT 
VPA1276_2F CAGGCATCGCAGTTCAAGTCGGGAACGCATAAATGAGAAGG
ATATA 
VPA1276_2R CACTAGTGACGCGTACTCGAGTTCACGAATTCTGCGGCTTA 
VPA1280_1F GCTTATCGATACCGTCGACCCTCGAGCTTGCACCCATATTC
ACAAATG 
VPA1280_1R CGACTTGAACTGCGATGCCTGGGAGAATCAACAGTCTTCAT
AAGT 
VPA1280_2F CAGGCATCGCAGTTCAAGTCGCTGTCGAACCGTATCCTAAG
T 
VPA1280_2R CACTAGTGACGCGTACTCGAGTTGATTGGCGATAGCTGCAA
T 
VPA1279-
1280_2F 
GCTTATCGATACCGTCGACCCTCGACACAGAGATAATGGAT
TCACCC 
VPA1279-
1280_1R 
CGACTTGAACTGCGATGCCTGTACCTGGCTTCAAAATTGGG
C 
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VPA1279-
1280_2F 
CAGGCATCGCAGTTCAAGTCGCCTAAGTAGTTAGAGAAAGC
CTG 
VPA1279-
1280_2R 
CACTAGTGACGCGTACTCGAGCAAATAGTCGTTGTAGAGCG 
VPA1276_PMMB
_RBS_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG
AACGAACAAGAAATCAAGCCATCC 
VPA1276_PMMB
_HIS_R 
TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGA
TGATGTGCGTTCCATGCATCCGG 
VPA1277_PMMB
_RBS_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG
AGAAGGATATATCTAGAGAGC 
VPA1277_PMMB
_HIS_R 
TCTCATCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGA
TGATGTTTAGGCAGAGATACGGTGAA 
VPA1279_PMMB
_RBS_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATATTG
AAGCCAGGTAAAACAGGAAT 
VPA1279_PMMB
_HIS_R 
TCCGCCAAAACAGCCAAGCTCTAATGGTGGTGGTGATGATG
AAGCAAGAACGACGCCC 
VPA1280_PMMB
_RBS_F 
GGTACCCGGGGATCCTCTAGTAAGGAGGTAGGATAATAATG
AAGACTGTTGATTCTCCAAAGA 
VPA1280_PMMB
_HIS_R 
TCCGCCAAAACAGCCAAGCTTTAATGGTGGTGGTGATGATG
GGATACGGTTCGACAGGT 
1277_T82A_1R AGCAGTGTGAGGTTGCAACAAT 
1277_T82A_2F ATTGTTGCAACCTCACACTGCTGATGAGCTCCCAC 
1277_L85A_1R AGCCTCATCCGTAGTGTGAG 
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1277_L85A_2F CTCACACTACGGATGAGGCTCCACCCGAGGTGAA 
1277_K90A_1R AGCCACCTCGGGTGGGA 
1277_K90A_2F TCCCACCCGAGGTGGCTGAAGTGTTCGATGA 
1277_E91A_1R AGCCTTCACCTCGGGTGG 
1277_E91A_2F CCACCCGAGGTGAAGGCTGTGTTCGATGAAG 
1277_V92A_1R AGCTTCCTTCACCTCGGGT 
1277_V92A_2F ACCCGAGGTGAAGGAAGCTTTCGATGAAGATCCTA 
1277_F93A_1R AGCCACTTCCTTCACCTCG 
1277_F93A_2F CGAGGTGAAGGAAGTGGCTGATGAAGATCCTAC 
1277_F113A_1R AGCGCGAAACCAAAAATCCC 
1277_F113A_2F GGGATTTTTGGTTTCGCGCTGACGAGAGCACTC 
1277_T82A_CF ATTGTTGCAACCTCACACTGCT 
1277_L85A_CF CTCACACTACGGATGAGGCT 
1277_K90A_CF TCCCACCCGAGGTGGCT 
1277_E91A_CF CCACCCGAGGTGAAGGCT 
1277_V92A_CF ACCCGAGGTGAAGGAAGCT 
1277_F93A_CF CGAGGTGAAGGAAGTGGCT 
1277_F113A_CF GGGATTTTTGGTTTCGCGCT 
VPA0242RT_F GCCATGATGACGGCGACAT 
VPA0242RT_R CACCTGCTGCGGCTTCTC 
VPA1280_RT_F ATGCACAGCAATCTTCGACC 
VPA1280_RT_R TACGGTCAAATTGATTGCGCGTT 
VPA1279_RT_F AAGCCGCGTGGACTCATG 
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VPA1279_RT_R TTTGGCTCGACCACTGAGTT 
VP2509_RT_F CAACATCGAGGCCGAACTC 
VP2509_RT_R CTGCTCACTGTGACACCTGA 
VPA0243RT_F CTTTGTACGCGTACACACCG 
VPA0243RT_R GTCTTCAGCGCTGTGCAGCA 
1277_SENDOMIN
_BAMHI_F 
AACGGATCCTATGAGCTCAATACTGATTATGACTA 
 
1277_SENDOMIN
_ECORI_R 
AACGAATTCTTAGTCGTCGAAATTGACGGCTT 
1277H221A_PDM
4_F 
GCTTATCGATACCGTCGACCCTCGAATGAGAAGGATATATCT
AGAGAGC 
1277H221A_PDM
4_R 
CACTAGTGACGCGTACTCGATTATTTAGGCAGAGATACGGT
GAA 
1277H221A_CPM
_F 
TCACCAATGCGGTTGCTGCT 
1277H221A_CPM
_R 
GCATGGCATTGCGAAGTAGG 
1276D58A_PDM4
_F 
GCTTATCGATACCGTCGACCCTCGAGCAGTAGAGACGGAAC
TGCT 
1276D58A_PDM4
_R 
CACTAGTGACGCGTACTCGATTATGCGTTCCATGCATCCGG 
1276D58A_CPM_
F 
CAACCCGATTTGGTTTTGTTAGC 
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1276D58A_CPM_
R 
CTGTTGGTTCATAGTGCAGGA 
1277H221A_PMM
B_R1 
AGCAGCAACCGCATTGGTGA 
1277H221A_PMM
B_F2 
TCACCAATGCGGTTGCTGCTGAGCTACGCACACCAATTTTTC 
1276H58A_PMM
B_1R 
AGCTAACAAAACCAAATCGG 
1276H58A_PMM
B_2F 
CCGATTTGGTTTTGTTAGCTTTGATGCTGCCGGGCCAAG 
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Figure 3-1. Identification of a histidine kinase that is essential for the resistance 
of V. parahaemolyticus to antimicrobial peptide antibiotics and vancomycin. (A) 
Mutants with deletion of predicted histidine kinases were streaked on LB agar 
plate containing 15 μg/mL polymyxinB. (C) Vpa1277 was designated as PvrK. 
Deletion of pvrK (vpa1277) or pvrR (vpa1276) abolished the ability of V. 
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parahaemolyticus to resist polymyxin E (colistin).  Point mutation of H221A to 
PvrK or D58A to PvrR also abolished the ability of V. parahaemolyticus to resist 
polymyxin E. Complementation of ΔpvrK with WT pvrK or ΔpvrR with WT pvrR 
restored polymyxin E resistance. (D) Deletion of vpa1277 abolished the ability of 
V. parahaemolytic to resist LL-37. (E) Deletion of pvrK (vpa1277) or pvrR 
(vpa1276) abolished the ability of V. parahaemolyticus to resist polymyxinB.  
Point mutation of H221A to PvrK or D58A to PvrR also abolished the ability of V. 
parahaemolyticus to resist polymyxinB. Complementation of ΔpvrK with WT pvrK 
or ΔpvrR with WT pvrR restored polymyxinB resistance. 
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Figure 3-2. PvrK is predicted to be a membrane protein with two potential 
transmembrane regions located at amino acids 8–21 and amino acids 140–161, 
respectively (http://tmdas.bioinfo.se/cgi-bin/tmdas.cgi).  
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Figure 3-3. KEGG pathways negatively affected in DpvrK mutants.   
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Figure 3-4. RT-PCR confirmation of transcription of pvrK regulon. Indicated 
strains were cultured in LB. House keeping gene gyrB as an internal control.  
 
 109 
 
Figure 3-5. In vivo phosphorylation analysis of PvrK or PvrKH221A in the indicated 
strains, and phosphorylation analysis of PvrR or PvrRD58A in the indicated strains. 
All strains are grown in LB.  
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Figure 3-6. PvrR does not form cognate RR with PvrK functionally. (A) 
Complementation of WT PvrR into ΔpvrR or pvrRD58A barely restored the ΔpvrR 
resistance to polymyxinB. All strains are grown on LB agar plates with 15ug/ml 
polymyxinB. (B) Phos-tag SDS-PAGE of PvrR. PvrR can be phosphorylated 
when PvrK is absent or mutated 
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Figure 3-7. AMP resistance of dagK and eptA. (A) Deletion of either dagK or eptA 
abolished AMP resistance; Complementation of both dagK and eptA to pvrK 
mutant fully restored polymyxinB resistance to WT level. (B) Deletion of both 
vpa1279-1280 genes abolished AMP resistance while complementation of 
Δvpa1279-1280 with WT Vpa1279-1280 restored the resistance. 
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Figre 3-8. High Mg2+ inhibits PvrK phosphorylation. (A) In vivo phosphorylation 
analysis of PvrK or PvrKH221A in LB or LB supplemented with 2mM and 10mM 
Mg2+. (B) RT-PCR analysis of eptA(vpa1280) and vpa0243 expression in pvrK or 
pvrKH221A complementation strain when growing in LB or LB with 10mM Mg2+, 
with gyrB as an internal control.  
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Figure 3-9. The role of AMP in the phosphorylation of PvrK when V. 
parahaemolyticus was cultured in LB with high concentration of Mg2+. (A) In vivo 
phosphorylation analysis of PvrK in LB, LB with 10mM Mg2+ and LB with 10mM 
Mg2+ and 10ug/ml polymyxin B. (B) RT-PCR analysis of eptA(vpa1280) and 
vpa0243 expression in pvrK or pvrKH221A complementation strain when growing in 
 114 
Lb, LB with 10mM Mg2+  or LB with 10mM Mg2+ and 10ug/ml polymyxin B, with 
gyrB as an internal control.  
 
 
 
Figure 3-10. Schematic model for PvrK/PvrR-mediated eptA expression. 
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